: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer, June 2026
Free Subscription

Abstracts
Retrieve all available abstracts of the following 449 articles:
HTML format

Single Articles

ACAR U, Barlas F, Beyazgul B, Koruk I, et al
Health belief model-based determinants of women's participation in cervical cancer screening: a case-control study from Southeastern Turkey.
BMC Womens Health. 2026 May 30. doi: 10.1186/s12905-026-04582.
PubMed
Abstract available

TESHALE MM, Kebede WM, Sahilu WT, Wondimu KS, et al
Depression among women with cervical cancer: a systematic review and meta-analysis of available evidence.
BMC Psychiatry. 2026 May 29. doi: 10.1186/s12888-026-08211.
PubMed
Abstract available

CHEN Q, Lyu J, Li Y, Zhang L, et al
Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches.
Cancer Immunol Immunother. 2026 May 29. doi: 10.1007/s00262-026-04439.
PubMed
Abstract available

WILKINS K, David O, Oguntoyinbo JO, Zainab H, et al
Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS.
Cancer Treat Res Commun. 2026;48:101256.
PubMed
Abstract available

MOORTHY A, Le NA, Issac A, Willmott L, et al
Brachytherapy use in cervical cancer: a narrative review.
Gynecol Pelvic Med. 2026;9:8.
PubMed
Abstract available

ZHANG J, Wei W, Zhang Y, Wang D, et al
Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma.
Front Immunol. 2026;17:1808107.
PubMed
Abstract available

GOULIARIS M, Papalaskari A, Katsapanteras P, Zoglopitou L, et al
Cervical Cancer Brachytherapy Dose Escalation Protocol: Analysis of Early Data Treatments According to EMBRACE II Protocol.
Cureus. 2026;18:e107803.
PubMed
Abstract available

YAN T, Ma Q, Shi H, Qi D, et al
Disease burden of cervical cancer in China from 1990 to 2023 and prediction of future trends.
Front Oncol. 2026;16:1802330.
PubMed
Abstract available

VAJDA G, Loczi L, Vida B, Merkely P, et al
Systemic inflammatory ratios and their added value to cytology in cervical cancer detection: a multicenter study.
Front Med (Lausanne). 2026;13:1802477.
PubMed
Abstract available

MAKIN J, Elishaev E, Durbin SM, Makin RA, et al
Diagnostic Accuracy of Entropy Based Image Analysis of Cervical Precancerous Cells.
J Biophotonics. 2026;19:e70294.
PubMed
Abstract available

YAMAMOTO R, Asano H, Hatanaka KC, Shinomiya Y, et al
Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.
J Gynecol Oncol. 2026 May 21. doi: 10.3802/jgo.2026.
PubMed
Abstract available

HWANG JH, Kim H
Comparison of clinical outcomes between early and delayed diagnosis of cervical cancer following abnormal Pap smear results: a population-based cohort study using National Health Insurance data in South Korea.
J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
PubMed
Abstract available

MA J, Wang G, Wang W, Yang H, et al
Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.
J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
PubMed
Abstract available

WU J, Yi J, Fang L, Lei S, et al
Urban-rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi'an, China.
BMC Infect Dis. 2026 May 28. doi: 10.1186/s12879-026-13647.
PubMed
Abstract available

LIU J, Jiao Y, Wang J, Cui X, et al
miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.
Hum Cell. 2026;39:81.
PubMed
Abstract available

MOORTHY S, Raj EH, Sundersingh S, Raja A, et al
Radiation-induced Osteosarcoma of the vaginal vault following cervical cancer treatment.
BMJ Case Rep. 2026;19:e269768.
PubMed
Abstract available

SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
Development and characterization of novel T-cell receptor-like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches.
Int J Biol Macromol. 2026 May 27:152755. doi: 10.1016/j.ijbiomac.2026.152755.
PubMed
Abstract available

ZHANG Y, Wu Y, Yuan J, Yang J, et al
A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer.
Int J Womens Health. 2026;18:603381.
PubMed
Abstract available

PATRA S, Shand H, Ghorai S
Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancer.
Immunotherapy. 2026 May 27:1-21. doi: 10.1080/1750743X.2026.2679883.
PubMed
Abstract available

WANG H, Zhu Y, Zhang B, Ding H, et al
Promoting cervical cancer screening participation among Chinese women from resource-limited settings: a multicenter qualitative study.
BMC Womens Health. 2026 May 27. doi: 10.1186/s12905-026-04546.
PubMed
Abstract available

LYU Q, Zhao J, Chen Y, Xiong J, et al
Molecular characterization of HPV integrations in high-risk HPV-positive women and development of a prognostic signature based on integration-associated genes for cervical cancer.
Infect Agent Cancer. 2026 May 27. doi: 10.1186/s13027-026-00766.
PubMed
Abstract available

CHEN L, Lin W, Huang Y, Li C, et al
Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer.
Cell Death Dis. 2026 May 27. doi: 10.1038/s41419-026-08902.
PubMed
Abstract available

WANG J, Tu Y, Chen Y, Luo L, et al
Cumulative dose assessment in combined radiotherapy for locally advanced cervical cancer using deformable image registration framework based on BTV dose uniformity.
Brachytherapy. 2026 May 27:S1538-4721(26)00070.
PubMed
Abstract available

LING HJ, Zhou JL, Cao LQ, Li R, et al
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process.
Cancer Genet. 2026;306-307:34-48.
PubMed
Abstract available

ZHANG C, Meng Q, Jiao H, Liu H, et al
HNRNPU K181 Lactylation Drives Cervical Cancer Growth by Upregulating PHGDH and Reprogramming Serine Metabolism.
Adv Sci (Weinh). 2026 May 27:e20222. doi: 10.1002/advs.202520222.
PubMed
Abstract available

XU C, Li H, Wu Y, Yao Q, et al
Investigation of the clinical value of artificial intelligence-derived prognostic signature in cervical cancer based on machine learning algorithms.
Discov Oncol. 2026 May 27. doi: 10.1007/s12672-026-05182.
PubMed
Abstract available

LUPKOWSKI R, Gorniak K, Lisik-Habib M, Burchardt E, et al
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
Antibodies (Basel). 2026;15:42.
PubMed
Abstract available

FARRUKH S, Kavcic N, Canarutto G, Piazza S, et al
Rethinking residual p53 function in HPV-positive cervical cancer cells.
J Virol. 2026 May 27:e0047925. doi: 10.1128/jvi.00479.
PubMed
Abstract available

WEI Y, Song F, Wang W
Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study.
Front Med (Lausanne). 2026;13:1813161.
PubMed
Abstract available

TULIMILLI SV, Karnik M, Cockroft S, Bettadapura ADS, et al
Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.
Oncol Rev. 2026;20:1760156.
PubMed
Abstract available

NAKASI R, Wamozo C, Nsumba S, Rukundo B, et al
Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation.
Front Digit Health. 2026;8:1776155.
PubMed
Abstract available

MISAWA Y, Mizuno S, Honda S, Shinohara R, et al
Koilocytosis in LSIL Cytology Has Limited Predictive Value for CIN2+ in HPV-Positive Women: Implications for Risk-Based Cytology Triage.
Pathogens. 2026;15:537.
PubMed
Abstract available

BONIFACIO-VELEZ DE VILLA E, Aguilar-Luis MA, Silva-Caso W, Becerra-Goicochea L, et al
Genetic Variability and Conserved T-Cell Epitope Prediction of the HPV16 E1 Protein in Cervix Samples from Peru.
Pathogens. 2026;15:526.
PubMed
Abstract available

ABASI X, Liang D, Rezhake R, Tuerxun G, et al
Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity.
Pharmaceuticals (Basel). 2026;19:686.
PubMed
Abstract available

MUSHASHA MP, Modiba LM
Strategies to Raise Awareness About Screening and Vaccination for the Human Papillomavirus Among Women in Limpopo Province, South Africa.
Int J Environ Res Public Health. 2026;23:657.
PubMed
Abstract available

WANG L, Ouyang Y, Zhao Q, Wang T, et al
The Mechanism of Mg(2+)-Mediated Inhibition of Cervical Cancer by Inducing a Senescence-like State via the ATM/CHK2/p21 Signaling Pathway.
Int J Mol Sci. 2026;27:4397.
PubMed
Abstract available

PAWLIK P, Kurzawinska G, Ozarowski M, Karpinski TM, et al
Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers-A Preliminary Study.
Int J Mol Sci. 2026;27:4302.
PubMed
Abstract available

JABLONSKA IA, Golawski M, Scieglinska D, Kacorzyk U, et al
Prognostic Value of Pretreatment Circulating Tumor HPV DNA Load in HPV-Associated Cancers: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2026;27:4263.
PubMed
Abstract available

SONGUR DAGLI S, Altun M
Acceptability of HPV Self-Sampling for Cervical Cancer Screening Among Previously Screened Women in Turkiye: A Cross-Sectional Study.
Healthcare (Basel). 2026;14:1312.
PubMed
Abstract available

GARCIA-BERNAL JR, Resendiz-Castillo LJ, Martinez-Barajas MG, Diaz-Palomera CD, et al
Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17beta-Estradiol Stimulation.
Cancers (Basel). 2026;18:1509.
PubMed
Abstract available

SUN C, Chu A, Liu S, Song R, et al
Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.
BMC Med Imaging. 2026 May 26. doi: 10.1186/s12880-026-02435.
PubMed
Abstract available

BUSAYO SE, Adewale FL, Ogundokun RO, Adewale OF, et al
Knowledge and Perception of Cervical Cancer and Pap-Smear Screening Among Antenatal Women in Ogun State, Nigeria.
Cancer Med. 2026;15:e71949.
PubMed
Abstract available

LIU Y, Wu R, Li C, Li R, et al
Systematic photodynamic therapy for concurrent cervical-vaginal high-grade squamous intraepithelial lesion: a series of eight cases.
Lasers Med Sci. 2026;41:102.
PubMed
Abstract available

ZHANG Z, Bussmann H, Vong S, Kol H, et al
A Micro-costing Study of Community-Based Primary HPV Self-Sampling and Triage Test for Cervical Cancer Screening in Rural Cambodia.
Pharmacoecon Open. 2026 May 26. doi: 10.1007/s41669-026-00659.
PubMed
Abstract available

SUSILADEWI IAMV, Afiyanti Y, Allenidekania A, Fitch M, et al
Perceptions and Behaviors of Healthcare Providers Regarding Sexuality in Cervical Cancer Care: A Qualitative Study.
Curr Oncol. 2026;33:253.
PubMed
Abstract available

ZHANG H, Chen X, Wang B, Li L, et al
Trim45 promotes the occurrence and development of cervical cancer by inhibiting the cGAS/STING signaling pathway.
Integr Biol (Camb). 2026;18:zyag009.
PubMed
Abstract available

BADAWY N, Alwadaany B, Safar H, Alshammaa M, et al
Knowledge and attitudes regarding cervical cancer among adult Kuwaiti women: A cross-sectional study.
Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-53363.
PubMed
Abstract available

XIE Z, Di L, He X, Huang M, et al
DNAJC9 promotes cervical cancer cell proliferation by regulating GLI1 expression.
Acta Biochim Biophys Sin (Shanghai). 2026;58.
PubMed
Abstract available

ZHANG T, Zhu J, Geng L, Jin Z, et al
FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARgamma/CPT1A signaling pathway.
Discov Oncol. 2026 May 25. doi: 10.1007/s12672-026-05268.
PubMed
Abstract available

LEE SS, Weil CR, Boyd L, Burt LM, et al
Trends in Intensity Modulated Radiation Therapy Utilization for Definitive Treatment of Intact Cervical Cancer, 2004-2019.
Adv Radiat Oncol. 2026;11:102043.
PubMed
Abstract available

LI Z, Pang X, Wang Z, Wen J, et al
PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report.
Front Immunol. 2026;17:1826847.
PubMed
Abstract available

WESSEL L, Arians N
Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions.
Transl Cancer Res. 2026;15:346.
PubMed

PAN H, Bao L, Shi W, Wan J, et al
RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.
Transl Cancer Res. 2026;15:317.
PubMed
Abstract available

GIANNECCHINI GV, Filgueiras ABT, de Andrade DAP, de Melo AC, et al
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
Transl Cancer Res. 2026;15:350.
PubMed

CAO L, Zhang C
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes.
Transl Cancer Res. 2026;15:271.
PubMed
Abstract available

LI P, Shao Y, Wang J, Lin R, et al
Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression.
PeerJ. 2026;14:e21255.
PubMed
Abstract available

CHEN H, She C, Wang Z, Huang X, et al
A ferroptosis-related lncRNAs risk score model identifies LINC02178 as a potential regulator of ferroptosis sensitivity in cervical cancer.
Front Oncol. 2026;16:1807953.
PubMed
Abstract available

SHINDE P, Ak A, Agarwal P, Kamalnath J, et al
Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.
Br J Radiol. 2026 May 21:tqag075. doi: 10.1093.
PubMed
Abstract available

XUE L, Li X, Guo X, Xing H, et al
Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers.
Hum Vaccin Immunother. 2026;22:2676391.
PubMed
Abstract available

FRUHAUF F, Fischerova D, Moro F, Kocian R, et al
Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.
Ultrasound Obstet Gynecol. 2026 May 24. doi: 10.1002/uog.70241.
PubMed
Abstract available

RATHOD G, Parmar P
HPV self-sampling in low-resource settings: An overlooked opportunity for cervical cancer screening.
Trop Doct. 2026 May 24:494755261454018. doi: 10.1177/00494755261454018.
PubMed
Abstract available

WOLDEAREGAY HG, Abebe GG, Weldemariam S, Tesfay FG, et al
Cervical cancer screening among HIV-positive women in conflict-affected and resource limited settings: the case of Tigray region, Ethiopia.
J Health Popul Nutr. 2026 May 23. doi: 10.1186/s41043-026-01331.
PubMed
Abstract available

LOGANATHAN T, Madhulekha S, Zayed H, C GPD, et al
Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach.
Adv Protein Chem Struct Biol. 2026;152:103-121.
PubMed
Abstract available

M TMS, S P, Selvasudha N, Sivadas S, et al
Plumbagin-PLA- chitosan nanoformulation ameliorates inflammation in cervical cancer (SiHa) cells by enhancing bioavailability and targeted drug delivery.
J Biomater Sci Polym Ed. 2026 May 23:1-26. doi: 10.1080/09205063.2026.2676164.
PubMed
Abstract available

GOVARTHAN PK, Agastinose Ronickom JF, Swaminathan R
Identification of Cervical Cancer Biomarkers Using Gene Co-Expression Networks and Machine Learning Methods.
Stud Health Technol Inform. 2026;336:398-402.
PubMed
Abstract available

TSUI J, Garcia S, Shin MB, Lui K, et al
Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.
BMC Prim Care. 2026 May 22. doi: 10.1186/s12875-026-03387.
PubMed
Abstract available

AGGARWAL A, Rolland P, Leung E, Morrison J, et al
Sentinel Lymph Node Sampling in Early-Stage Cervical Cancer: A Cross-Sectional Survey.
BJOG. 2026 May 22. doi: 10.1111/1471-0528.70268.
PubMed

ABOELNASR LS, Patel J, Thomson AR, Yazbek J, et al
Concurrent uterine and pelvic angiolipoleiomyomas.
BMJ Case Rep. 2026;19:e270120.
PubMed
Abstract available

ILGEN O, Karatasli V
RETROPERITONEAL SENTINEL LYMPH NODE DISSECTION USING VNOTES IN EARLY-STAGE CERVICAL CANCER: A CASE REPORT.
J Minim Invasive Gynecol. 2026 May 21:S1553-4650(26)00283.
PubMed
Abstract available

JIA Z, Zhang J, Liu X, Liu C, et al
ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathway.
Cancer Genet. 2026;306-307:1-6.
PubMed
Abstract available

VANICHBUNCHA T, Leetanaporn K, Hanprasertpong J
Impact of the diagnosis-surgery interval on survival outcomes and development of a nomogram for predicting survival in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database analysis.
J Gynecol Oncol. 2026 May 14. doi: 10.3802/jgo.2026.
PubMed
Abstract available

ZHANG H, Zhou H, Li M, Mutailipu T, et al
Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China.
J Gynecol Oncol. 2026 May 18. doi: 10.3802/jgo.2026.
PubMed
Abstract available

HU Y, Chen S, Cheng H, Han Y, et al
Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial.
J Gynecol Oncol. 2026 Apr 29. doi: 10.3802/jgo.2026.
PubMed
Abstract available

PAFENG J, Celaya A, Gay S, Fuentes D, et al
RADIANT: A fully configurable radiotherapy dose prediction framework.
Biomed Phys Eng Express. 2026;12.
PubMed
Abstract available

ZHOU Q, Du H, Gao Y, Zhang Q, et al
Baicalin induces ferroptosis in cervical squamous cell carcinoma via the NRF2/SLC7A11/GPX4 signaling axis.
Biochem Biophys Res Commun. 2026;822:153876.
PubMed
Abstract available

SARRIA H, Bernal G
Prevalence of human papillomavirus in the public health system of the central-northern region of Chile.
Diagn Microbiol Infect Dis. 2026;116:117451.
PubMed
Abstract available

LAL S, Pradhan A, Sherpa ML
"HPV 16/18 E6 DNA and mRNA expression in gross cervical lesions: A hospital based cross-sectional study from Sikkim, India".
Cancer Treat Res Commun. 2026;47:101209.
PubMed
Abstract available

WANG X, Xu J, Zhang H, Qu P, et al
Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinoma.
Cancer Treat Res Commun. 2026;47:101187.
PubMed
Abstract available

DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme.
Clin Epigenetics. 2025;18:97.
PubMed
Abstract available

SMIT F, Braggion A, Cullati S, Chiolero A, et al
Cancer screening after the age of 75: Nationwide population-based trends.
J Med Screen. 2026;33:122-126.
PubMed
Abstract available

MUNJAL V, Schupack KM, Miller NE, Boswell CL, et al
Retrospective analysis of clinician and patient factors associated with unsatisfactory Pap tests.
J Med Screen. 2026;33:94-99.
PubMed
Abstract available

ANDERSSON H, Nordqvist Kleppe S, Edvardsson H, Elfstrom KM, et al
Quality indicators for cervical screening in Sweden.
J Med Screen. 2026;33:84-93.
PubMed
Abstract available

NAIDOO L, Nxele S, Yusuf-Saka T
Enhancing cervical cancer screening coverage in selected primary healthcare sites using Lean thinking: The CerviScreen programme.
S Afr Med J. 2026;116:e3654.
PubMed
Abstract available

ANGELILLO S, Miraglia Del Giudice G, Della Polla G, Angelillo IF, et al
Cervical cancer and screening: Knowledge, attitudes, and adherence among university students in Italy.
Hum Vaccin Immunother. 2026;22:2682535.
PubMed
Abstract available

XU M, Kang K, Zhao M, Bi S, et al
Optimizing ovarian dose sparing for young cervical cancer patients after oophoropexy: a dosimetric and radiobiological comparison of three radiotherapy techniques (IMPT, TOMO, and VMAT).
Radiat Oncol. 2026 Jun 4. doi: 10.1186/s13014-026-02862.
PubMed
Abstract available

ZOU Z, Zhai B
A systematic review of barriers to cervical cancer screening among Thai women based on the social ecological model: a multi-level analysis of local evidence.
Sex Health. 2026;23:SH26059.
PubMed
Abstract available

WENG X, Zeng C, Lv J, Huang F, et al
Exosomes derived from M2-polarized tumor-associated macrophages contribute to immune escape in cervical cancer.
Biochem Biophys Res Commun. 2026;828:154046.
PubMed
Abstract available

FAROOQI AA, Attar R, Gasparri ML, Berardi R, et al
Emerging landscape of oncogenic signaling pathways in cervical cancer.
Discov Oncol. 2026 Jun 4. doi: 10.1007/s12672-026-05271.
PubMed
Abstract available

BOTO T, Feketshane AM, Ngxola N
Evaluating knowledge and awareness of cervical cancer, human papillomavirus and human papillomavirus vaccination among women in East London, South Africa.
Afr J Prim Health Care Fam Med. 2026;18:e1-e6.
PubMed
Abstract available

WANG T, Zheng X, Chen B, Xiao R, et al
Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches.
Front Med (Lausanne). 2026;13:1777235.
PubMed
Abstract available

GARIN C, Daix M, Bresson L, Navarro AS, et al
Step-by-step type III total pelvic exenteration with vaginectomy and partial vulvectomy with complex pelvic reconstruction for vaginal recurrence of cervical cancer.
Gynecol Oncol Rep. 2026;65:102109.
PubMed

SELVA RAJAN R, Dass SA, Sachit BA, Tye GJ, et al
Development of a new diagnostic tool for detecting cervical cancer using a TCR-like antibody targeting the HPV 16 oncoprotein E7.
Eur Rev Med Pharmacol Sci. 2026;30:164-180.
PubMed
Abstract available

LIU T, Chen J, Dai B, Du D, et al
TRIM71 suppresses cervical cancer progression by inhibiting Nectin4-mediated Wnt/beta-catenin signaling.
Biol Direct. 2026 Jun 3. doi: 10.1186/s13062-026-00843.
PubMed
Abstract available

AKAGAWA J, Sera T, Yuasa Y
[Impact of Source Position Error in Tandem-ovoid Applicator on Dose Distribution in Cervical Cancer Brachytherapy].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2026;82.
PubMed
Abstract available

MURPHY EC, Rowen TS
Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.
Obstet Gynecol Clin North Am. 2026;53:339-351.
PubMed
Abstract available

PAPENBURG J, Pollock K, Yansouni CP
Increasing participation in cervical cancer screening.
BMJ. 2026;393:e353462.
PubMed

LI B, Liu Y, Pan Y, Zhang Y, et al
Dnq-unet: a two-level fusion framework for few-shot domain adaptation in cervical cancer CTV segmentation.
Radiol Phys Technol. 2026 Jun 3. doi: 10.1007/s12194-026-01072.
PubMed
Abstract available

TANG Y, Ning L, Yang X, Li N, et al
Construction and validation of a novel prognostic risk model in cervical cancer: integrating lactylation-related genes linked to radiotherapy?associated transcriptional changes.
Discov Oncol. 2026 Jun 3. doi: 10.1007/s12672-026-05351.
PubMed
Abstract available

Statement of Retraction: Amygdalin Induces Apoptosis in Human Cervical Cancer Cell Line HeLa Cells.
Immunopharmacol Immunotoxicol. 2026 Jun 3:1. doi: 10.1080/08923973.2026.2675070.
PubMed

BILEK Y, Hakki Sarpun I, Koca T
Can volumetric arc therapy be an alternative to brachytherapy in advanced cervical cancer radiotherapy?
Radiat Prot Dosimetry. 2026;202:720-725.
PubMed
Abstract available

MANIYAR AI, Alva RC, Koushik K, Nithyanand S, et al
Enhancing brachytherapy in cervical cancer: Initial dosimetric experience and assessment of Tulip hybrid applicator - the Add-On advantage.
J Contemp Brachytherapy. 2026;18:32-39.
PubMed
Abstract available

MOUSSAVOU-BOUNDZANGA P, Ambounda NL, Zinsou BE, Bivigou-Mboumba B, et al
Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015-2021).
Front Oncol. 2026;16:1735802.
PubMed
Abstract available

WANG Y, Jin X, Zhao S, Zhang Z, et al
Trajectory changes of symptom clusters in patients with concurrent chemoradiotherapy for cervical cancer: a prospective longitudinal study.
Front Oncol. 2026;16:1808208.
PubMed
Abstract available

ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
Nutritional status of patients diagnosed with cervical cancer in Tanzania.
BMC Nutr. 2026 Jun 2. doi: 10.1186/s40795-026-01323.
PubMed
Abstract available

BAYKEMAGN ND, Alemu GG, Tewelgne MF, Bicha AT, et al
Predicting knowledge of cervical cancer screening among reproductive-age women in sub-saharan africa using machine learning algorithms.
Sci Rep. 2026 Jun 2. doi: 10.1038/s41598-026-54976.
PubMed
Abstract available

BOGART LM, Whitaker L, Gwokyalya V, Beyeza-Kashesya J, et al
A Qualitative Analysis of Factors Contributing to Cervical Cancer Screening Implementation in Health Care Facilities in Uganda.
Cancer Control. 2026;33:10732748261450722.
PubMed
Abstract available

HUANG L, Feng W, Long W, Liu H, et al
Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.
Mol Cell Biochem. 2026 Jun 2. doi: 10.1007/s11010-026-05572.
PubMed
Abstract available

NOORANI S, Tang KS, Patel A, Tran D, et al
Cancerous Arrhythmia: Metastatic Cervical Cancer to the Heart Complicated by Ventricular Tachycardia.
JACC Case Rep. 2026 Jun 2:108560. doi: 10.1016/j.jaccas.2026.108560.
PubMed
Abstract available

BROWN C, McNally GA
The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.
Clin J Oncol Nurs. 2026;30:231-235.
PubMed
Abstract available

MILLS D, Sridharan S, Govindarajulu G
Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions.
J Med Imaging Radiat Oncol. 2026 Jun 2. doi: 10.1111/1754-9485.70130.
PubMed
Abstract available

YOSHIMURA T, Tatsuta I, Suzuki T, Tsuchino Y, et al
Feasibility and Short-Term Outcomes of an endoCUT-Based Non-Ligation Cervical Conization Strategy: A Single-Center Retrospective Study.
J Obstet Gynaecol Res. 2026;52:e70349.
PubMed

GU X, Shen T, Guo XK
Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
Nutr Rev. 2026 Jun 2:nuag096. doi: 10.1093.
PubMed

HUA Y, Li Y, Qin H, Huo M, et al
Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
Nutr Rev. 2026 Jun 2:nuag097. doi: 10.1093.
PubMed

ZHAO G, Al Ramadhan MM, Zhang Y
Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis.
PeerJ. 2026;14:e21337.
PubMed
Abstract available

PASSARELLA G, Vella S, Ferrario E, Provinciali N, et al
Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.
Front Oncol. 2026;16:1796299.
PubMed
Abstract available

WANG Q, Li Y, Shen L, Zhang Y, et al
Prediction of myelosuppression risk in postoperative cervical cancer patients undergoing concurrent chemoradiotherapy using machine learning models.
Front Oncol. 2026;16:1800585.
PubMed
Abstract available

MANGA SM, Randolph I, Ugwu L, Lee G, et al
Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.
Gynecol Oncol Rep. 2026;65:102105.
PubMed
Abstract available

SHAH S, Shah D, Shah H, Parmar J, et al
Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options.
Indian J Surg Oncol. 2026;17:1045-1051.
PubMed
Abstract available

RAJU K, Kukkamgai HM, Kamarthi PP
Evolution of Cervical Cancer Screening Techniques: A Concept of Translation Medicine.
Indian J Surg Oncol. 2026;17:1159-1170.
PubMed
Abstract available

KAO PY, Chen JH, Chen KH
The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment.
Oncol Res. 2026;34:12.
PubMed
Abstract available

CHEN X, Xue Z, Zhao S, Sun L, et al
Clinical manifestations and ultrasonographic features of lobular endocervical glandular hyperplasia: a retrospective study of 135 patients.
Ann Med. 2026;58:2673627.
PubMed
Abstract available

FERLA S, De Gobbi V, Seracchioli R, Raimondo D, et al
Laparoscopic cervical cerclage at 10 weeks gestation in a patient with an adverse obstetric history following fertility-sparing surgery for cervical cancer.
Facts Views Vis Obgyn. 2026 Jun 1. doi: 10.52054/FVVO.2026.
PubMed
Abstract available

BISCHOF K, Fredriksen KM, Bjornstad M, Elstrand MB, et al
Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort.
Acta Oncol. 2026;65:518-524.
PubMed
Abstract available

ZHENG X, Pan D, Lin J, Xiao J, et al
Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology-Positive Cervical Lesions.
Cancer Med. 2026;15:e72002.
PubMed
Abstract available

XU S, Zou Y, Wu Z, Xu Z, et al
Deep learning-based cervical cancer T-staging using MRI: multi-structure segmentation and classification.
BMC Med Imaging. 2026 May 30. doi: 10.1186/s12880-026-02449.
PubMed
Abstract available

MARZHOSEYNI Z, Shayestehpour M, Shaghaghi Z, Alvandi M, et al
Streptococcus-derived CpsA-CpsC fusion protein induces apoptosis in cervical cancer cells through in silico and in vitro methods.
Sci Rep. 2026 May 30. doi: 10.1038/s41598-026-55464.
PubMed
Abstract available

DIAZ-OBREGON D, Paco-Fernandez M, Ladera-Castaneda M, Huamani-Contreras M, et al
Implementation of HPV Self-Sampling in Cervical Cancer Screening Programs: A Bibliometric Analysis of Research Output, Global Trends, and Collaboration Networks.
Biomed Res Int. 2026;2026:e9345778.
PubMed
Abstract available

HAMID MR, Mohd Yunus N, Abdul Aziz AA, Azwari Annuar A, et al
Genetic polymorphisms of XRCC1 on cervical cancer susceptibility risk.
Med J Malaysia. 2026;81:356-361.
PubMed
Abstract available

NOVIANTI L, Calvin D, Feharsal Y, Candrani FVD, et al
Cervical cancer survival rate after abdominal vs. laparoscopic radical hysterectomy in two government hospitals in Jakarta, Indonesia.
Med J Malaysia. 2026;81:337-342.
PubMed
Abstract available

HAMAD RS, Doghish AS, Abdel Mageed SS, Rizk NI, et al
MicroRNAs in HPV-Associated Carcinogenesis: Potential Biomarkers in Oropharyngeal and Cervical Cancers.
IUBMB Life. 2026;78:e70117.
PubMed
Abstract available

ANTANO-ARIAS R, Torres-Rojas FI, Campos-Viguri GE, Arizmendi-Izazaga A, et al
miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.
Front Biosci (Landmark Ed). 2026;31:51227.
PubMed
Abstract available

SUGAWARA M, Nishio H, Iwata T, Katoh Y, et al
Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma.
J Gynecol Oncol. 2026;37:e101.
PubMed
Abstract available

STEFANOS R, Gargano JW, Niccolai LM, Castilho JL, et al
Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.
Cancer Epidemiol Biomarkers Prev. 2026;35:913-920.
PubMed
Abstract available

KESHARWANI P, Nasir N, Wahab S, Gupta G, et al
PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment.
Cancer Sci. 2026 Mar 31. doi: 10.1111/cas.70361.
PubMed
Abstract available

IVERSEN L, Raja EA, Nath M, Lip G, et al
The influence of rural residency on the uptake of screening for breast, cervical, and colorectal cancers in Scotland.
J Public Health (Oxf). 2026;48:467-476.
PubMed
Abstract available

IRIE G, Kobayashi Y, Shikama A, Yoshino M, et al
Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.
J Gynecol Oncol. 2026;37:e47.
PubMed
Abstract available

WEI S, Li X, Liu Z, Wei L, et al
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.
J Gynecol Oncol. 2026;37:e46.
PubMed
Abstract available

NAKAZAWA M, Teramoto M, Saito T
Therapeutic efficacy of laser vaporization and conization for high-grade cervical intraepithelial neoplasia.
J Gynecol Oncol. 2026;37:e34.
PubMed
Abstract available

CHIKAZAWA K, Fujimori A, Imai K, Ko H, et al
Laparoscopic radical hysterectomy after the LACC trial, avoiding uterine manipulator, pre-colpotomy vaginal washing and clamping, and uterine removal using a retrieval bag: a retrospective study.
J Gynecol Oncol. 2026;37:e40.
PubMed
Abstract available

HARGIS A, Berg CJ, Le D
Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.
J Cancer Educ. 2026;41:588-600.
PubMed
Abstract available

CHENG J, Shi Y, Jiang Q, Lin C, et al
Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression.
Discov Oncol. 2026 Jun 12. doi: 10.1007/s12672-026-05375.
PubMed
Abstract available

ABOAGYE ES, Abioke UB, Ogugua CE, Danquah F, et al
Knowledge and Preventive Practices Regarding Cervical Cancer Among Women in Nkoranza South Municipality, Ghana: A Cross-Sectional Study.
Cureus. 2026;18:e108654.
PubMed
Abstract available

CHANG CS, Na J, Seo JH, Lee YY, et al
Diagnostic performance of cervical cytology in HPV-independent cervical cancer: a comparative analysis with HPV-associated cases.
J Gynecol Oncol. 2026 Jun 1. doi: 10.3802/jgo.2026.
PubMed
Abstract available

YOON S, Baek HJ, Choi B, An HJ, et al
Schwannoma Mimicking Neck Nodal Metastasis on F-18 FDG PET/CT in Cervical Cancer: A Case Report with a Multimodal Approach.
Diagnostics (Basel). 2026;16:1686.
PubMed
Abstract available

SUBAIEA GM, Amangelsin Y, Sagatbekova K, Katamesh AA, et al
Phenformin-Induced Apoptosis: A Potential Mechanism for Cervical Cancer Cell Inhibition.
Int J Mol Sci. 2026;27:4941.
PubMed
Abstract available

BROCHWITZ E, Nel I, Eckardt A, Weydandt L, et al
Disseminated Tumor Cells (DTCs) in Patients with Cervical Cancer Reveal Mesenchymal Properties and Potential Therapeutic Targets-A New Perspective?
Int J Mol Sci. 2026;27:4875.
PubMed
Abstract available

PUTRA AD, Safika S, Fadilah F, Nuryanto KH, et al
Computational and Cytotoxicity Evaluation of Phyllanthus Urinaria-Derived Compounds as Potential Anti-Cervical Cancer Agents via HPV-16 E6 Oncoprotein Inhibition.
Int J Mol Sci. 2026;27:4780.
PubMed
Abstract available

SUN F, Wang Z
TMEM132A promotes cervical cancer progression via HOMER3-mediated activation of FAK/PI3K/AKT signaling pathway.
Sci Rep. 2026 Jun 11. doi: 10.1038/s41598-026-54987.
PubMed
Abstract available

ZHANG Y, Sun M, Li M, Zhang M, et al
Novel peptide Aurein1.2 derivative induces cytotoxicity in cervical cancer SiHa and HeLa cells by apoptosis and cell cycle arrest.
Toxicol Appl Pharmacol. 2026 Jun 11:117908. doi: 10.1016/j.taap.2026.117908.
PubMed
Abstract available

LIU Y, Wang S, Xia X, Zhang T, et al
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway.
Discov Oncol. 2026 Jun 11. doi: 10.1007/s12672-026-05425.
PubMed
Abstract available

OZAN E, Tuncer MC, Ozdemir I
Gallic Acid Potentiates Cisplatin Response in Cervical Cancer Cells Through Coordinated Cellular and Molecular Alterations.
Biology (Basel). 2026;15:825.
PubMed
Abstract available

CANTIDIO FS, Costa Diniz PH, Gil G, Silva-Filho AL, et al
Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy.
Cochrane Database Syst Rev. 2026;6:CD016258.
PubMed
Abstract available

OSHODIN AE, Ehikioya EE, Okobi OE, Njoku AI, et al
Diagnostic accuracy of visual inspection with acetic acid versus Papanicolaou smear in cervical cancer screening among HIV-positive women in rural Nigeria.
Afr J Reprod Health. 2026;:28-37.
PubMed
Abstract available

AZIZI M, Hong JS, Spitzberg J, Weissleder R, et al
Hydrogel-based multiplexed high-risk human papillomavirus DNA/RNA detection for cervical cancer screening.
Biosens Bioelectron X. 2025;26:100664.
PubMed
Abstract available

WASHINGTON A, Houck KF, Nelson BW, Harper DM, et al
Corrigendum to "Black US women share their experiences with follow-up after abnormal cervical cancer screening" [(2025) 100658 10].
Public Health Pract (Oxf). 2026;11:100727.
PubMed
Abstract available

XIA J, Sun J, Lu D
Early Screening for Cervical Squamous Cell Carcinoma and Precancerous Lesions Based on Surface-Enhanced Raman Spectroscopy Microarray Chips.
Int J Nanomedicine. 2026;21:606920.
PubMed
Abstract available

KUCUKCERAN H, Demirbas N, Karaoglu N, Cihan FG, et al
Evaluation of Knowledge About Human Papillomavirus and Vaccination Among Women Screened for Cervical Cancer.
Int J Health Plann Manage. 2026 Jun 11. doi: 10.1002/hpm.70094.
PubMed
Abstract available

DIZENDORF E, Miriyala R, Sreelakshmi KK, Tatli H, et al
Online educational program for CT-based image-guided adaptive brachytherapy in cervical cancer: The BrachyAcademy experience.
Brachytherapy. 2026 Jun 10:S1538-4721(26)00068.
PubMed
Abstract available

WU C, Huang L, Xu J, Liu G, et al
OGT-mediated O-GlcNAcylation of STAT1 impairs its Ser727 phosphorylation and weakens antitumor immunity of tumor-associated macrophages in cervical cancer.
Biochem Biophys Res Commun. 2026;828:154090.
PubMed
Abstract available

VAMSI GADE VK, Sharma J, Maity S, Bhattacharyya T, et al
Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic.
JCO Glob Oncol. 2026;12:e2500765.
PubMed
Abstract available

SHI F, Xuan Y, Zhu Y, Wu S, et al
Efficacy and safety of combined immune therapy for advanced cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2026;16:1772054.
PubMed
Abstract available

GWAYI SD, Tomoka T, Chimusa ER, Fedoriw G, et al
Burden of rare genetic variants in genes associated with cancer among Malawian cervical cancer patients.
Afr J Lab Med. 2026;15:3073.
PubMed
Abstract available

CHAVEZ-RIOS A, Lopez-Ruiz C, Garcia-Aguirre IA, Ocadiz-Delgado R, et al
Synergistic Interaction Between HPV-16 E7 Oncoprotein and Severe Vitamin A Deficiency in Regulating Adaptive Immunity in a Preclinical Cervical Cancer Model.
J Med Virol. 2026;98:e70992.
PubMed
Abstract available

GONG C, Xia X, Zhang X, Ye Y, et al
Longitudinal Study of Symptom Cluster Trajectories and Sentinel Symptoms in Patients With Cervical Cancer After Surgery and During the First Chemotherapy Cycle.
Cancer Nurs. 2026 May 28. doi: 10.1097/NCC.0000000000001596.
PubMed
Abstract available

ZHOU Y, Luo Y, Ge Y, Wu X, et al
Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression.
Cell Death Dis. 2026 Jun 9. doi: 10.1038/s41419-026-08960.
PubMed
Abstract available

GUI N, Pan H, Lu W, Pan G, et al
AGPAT family members act as potential predictive biomarkers and therapeutic targets in cervical cancer.
Discov Oncol. 2026 Jun 9. doi: 10.1007/s12672-026-05322.
PubMed
Abstract available

SERGISON JE, Alspaugh A, Janek S, Stevenson EL, et al
Scoping Review of Barriers and Facilitators of Cervical Cancer Screening in Appalachia.
Nurs Res. 2026 Jun 9. doi: 10.1097/NNR.0000000000000923.
PubMed
Abstract available

LIU WY, Huang HW, Ma JN, Xue L, et al
PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis.
Hum Mol Genet. 2026;35:ddag044.
PubMed
Abstract available

FAN M, Yang F, Zhang D, Dang H, et al
Demographic and Screening-to-Diagnosis Cascade Indicators for Risk Stratification in an Organized Cervical Cancer Screening Program: Evidence from 82,141 Women in Yunnan, China.
Int J Womens Health. 2026;18:602135.
PubMed
Abstract available

LIU L, Chen N, Zhu Q, Liu Q, et al
Effect of prophylactic HPV vaccination and timing of administration on recurrence of cervical HSIL after LEEP: A retrospective study.
Medicine (Baltimore). 2026;105:e49167.
PubMed
Abstract available

WU L, Chen L, Li D, Zhu Y, et al
Tisotumab vedotin versus chemotherapy in Chinese patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy.
Chin Med J (Engl). 2026 Jun 8. doi: 10.1097/CM9.0000000000004094.
PubMed

ZHAN J, Liu D, Ye J, Peng X, et al
C3(+) cancer-associated fibroblast-derived GAS6 promotes cervical cancer metastasis via activation of AXL signaling pathway in a syngeneic orthotopic mouse model.
J Transl Med. 2026 Jun 8. doi: 10.1186/s12967-026-08392.
PubMed
Abstract available

YANG J, Zhou M, Gao M, Lin C, et al
Reproductive tract commensal bacterium Enterococcus faecium supernatant induces DNA damage associated stress responses and suppresses the growth of cervical cancer cells.
BMC Microbiol. 2026 Jun 8. doi: 10.1186/s12866-026-05244.
PubMed
Abstract available

ZHOU J, Huang Q, Yang H, Liu Q, et al
Network Pharmacology and in vitro Experimental Validation Reveal the Anticancer Mechanisms of Cichoric Acid in Cervical Cancer.
Ann Clin Lab Sci. 2026;56:182-201.
PubMed
Abstract available

HUO M, Zhang H, Hua Y, Qin H, et al
Multiple roles of circRNAs in cervical cancer: From fundamental carcinogenic mechanisms to clinical application prospects.
Crit Rev Oncol Hematol. 2026;225:105390.
PubMed
Abstract available

ZHANG R, Chavana AN, Shi Y, Zhou B, et al
Dosimetric comparison of high dose rate interstitial brachytherapy and stereotactic body radiotherapy as alternative treatment methods for advanced-stage cervical cancer.
Biomed Phys Eng Express. 2026 Jun 8. doi: 10.1088/2057-1976/ae7979.
PubMed
Abstract available

CHI F, Jiang X, Zhou W, Chen Z, et al
A study on the effects of intrafractional changes in bladder volume on positional accuracy and target dosimetry in online adaptive radiotherapy for cervical cancer.
Appl Radiat Isot. 2026;236:112738.
PubMed
Abstract available

BRUNEAU N, Balanda M, San Martin H, Roldan F, et al
HPV Trends and Genotypes in Chilean and Immigrant Women: 10-Year Surveillance Study (2014-2023).
Rev Med Chil. 2026;154:339-350.
PubMed
Abstract available

ALLAMEH FZ, Sabet F, Behnamfar F, Seresht LM, et al
Uterine Cervical Cancer: Diagnostic Accuracy of Clinical Staging, Magnetic Resonance Imaging, and Histopathology Findings.
Iran J Nurs Midwifery Res. 2026;31:233-237.
PubMed
Abstract available

CHENG Y, Li X, Yan D
Single Cell and Machine Learning-Based Analysis of Lysosome Mediated Cell Death Reveals Novel Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer.
Int J Genomics. 2026;2026:8487184.
PubMed
Abstract available

KILIC EI, Kilic S
DeepInsight-Net: a CBAM-enhanced ResNet50 framework with focal loss for robust cervical cancer classification on multi-center datasets.
Front Med (Lausanne). 2026;13:1783634.
PubMed
Abstract available

ZAIDI A, Kameleen F, Saleem MS, Raza AA, et al
HPV vaccination and cervical cancer prevention in Pakistan: Why are we so far behind?
Ann Med Surg (Lond). 2026;88:3846-3847.
PubMed
Abstract available

ZHANG D, Meng Y, Dong X, Huang C, et al
Efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents in advanced cervical cancer: a systematic review and meta-analysis.
Front Immunol. 2026;17:1747768.
PubMed
Abstract available

BAIDEN-AMISSAH REM, Tuyaerts S, Annibali D, Herreros-Pomares A, et al
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial.
Front Immunol. 2026;17:1794131.
PubMed
Abstract available

SINGALAGA DD, Daryanto B, Purnomo AF
Success rate of Double J stent insertion in patients with advanced cervical cancer and hydronephrosis at tertiary hospital.
Arch Ital Urol Androl. 2026 Jun 5:15582. doi: 10.4081/aiua.2026.15582.
PubMed
Abstract available

IIJIMA K, Okamoto H, Ushijima T, Ueda Y, et al
Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi-institutional tool for training, quality assurance, and variability reduction.
J Appl Clin Med Phys. 2026;27:e70620.
PubMed
Abstract available

DAMASCO BJ, Plete MT
Bridging knowledge and practice: strengthening cervical cancer screening uptake among rural women in low-resource settings.
Rural Remote Health. 2026;26:11298.
PubMed

BUHAY BR, Chin JD, Han RY, Wakefield MR, et al
Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer.
Crit Rev Oncol Hematol. 2026;225:105428.
PubMed
Abstract available

CHEN Y
Single-cell transcriptomics and machine learning unveil liquid-liquid phase separation-related biomarkers in HPV-positive cervical cancer.
Infect Agent Cancer. 2026 Jun 6. doi: 10.1186/s13027-026-00768.
PubMed
Abstract available

HUANG X, Santo T Jr
Letter to the editor on "Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening".
Cancer Lett. 2026 Jun 5:218648. doi: 10.1016/j.canlet.2026.218648.
PubMed

MA S, Lin J, Deng X, Li Z, et al
Hsa_circ_0000231 activates the MAPK pathway via IGF2BP2-mediated CACNA1H mRNA stabilization to promote cervical cancer progression.
Discov Oncol. 2026 Jun 6. doi: 10.1007/s12672-026-05378.
PubMed
Abstract available

LIN Y, Shuang P, Tao D, Lu L, et al
Anesthetic management of a patient with malignant right ventricular tumor and pulmonary tumor embolism secondary to cervical cancer: a case report.
J Cardiothorac Surg. 2026 Jun 5. doi: 10.1186/s13019-026-04354.
PubMed
Abstract available

WU J, Li R, Chen H
Comparison of open and minimally invasive radical hysterectomy for cervical cancer: a systematic review and meta-analysis of survival outcomes.
BMC Surg. 2026 Jun 6. doi: 10.1186/s12893-026-03878.
PubMed
Abstract available

BRUCKER P, Horn S, Jansari S, Kombou M, et al
Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer.
Cell Death Discov. 2026;12:270.
PubMed
Abstract available

ADAMS ED
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.
J Obstet Gynecol Neonatal Nurs. 2026 Jun 5:S0884-2175(26)00148.
PubMed
Abstract available

HE J, Yan R, Du Y, Yang H, et al
TRPS1 inhibits cervical cancer progression by suppressing ORC6-mediated tumor stemness.
Tissue Cell. 2026;103:103655.
PubMed
Abstract available

RASHEED AHRS, Sekar PKC, Sreevalsan A, Veerabathiran R, et al
Oncogenic impact of PIK3CA, KRAS, and PTEN mutations in cervical cancer among South Indian women.
Adv Clin Exp Med. 2026 Jun 5. doi: 10.17219/acem/209713.
PubMed
Abstract available

KUMAR S, Kaul P, Kapur K, Choudhary D, et al
Cancer screening uptake and tobacco-alcohol use among women in Uttarakhand: A district-wise analysis from the 5th National Family Health Survey (NFHS-5).
Indian J Med Res. 2026;163:625-629.
PubMed
Abstract available

WANG R, Wang J, Ruan J, Gao C, et al
Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.
Signal Transduct Target Ther. 2026;11:214.
PubMed
Abstract available

ADLER D, Wood N, Merriman J, Abar B, et al
Self-collection for HPV testing among emergency department patients: A prospective, interventional, single-arm, feasibility study.
Am J Emerg Med. 2026;107:33-38.
PubMed
Abstract available

OPALEYE OO, Esan DT
Mobile health strategies to improve HPV vaccination uptake among parents of adolescent girls: a scoping review.
Vaccine. 2026;85:128701.
PubMed
Abstract available

YIN L, Zhang J, Pang Y, Mou Y, et al
Blood Oxygenation Level-Dependent MRI for Predicting Lymphovascular Space Invasion in Cervical Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy: A Prospective Study.
Acad Radiol. 2026;33:2934-2945.
PubMed
Abstract available

TANAKA Y, Otsuka A, Goto T, Shiki Y, et al
Anatomical Highlights During Nerve-Sparing Radical Hysterectomy: A Step-by-Step Educational Video.
Ann Surg Oncol. 2026;33:6652-6653.
PubMed
Abstract available

TALIA KL, Soong TR, Kiyokawa T, de Brot L, et al
Assessment of lymphovascular space invasion in cervical squamous cell carcinoma using digital pathology: a reproducibility study.
Histopathology. 2026;89:154-162.
PubMed
Abstract available

CINTRA RC, Hsu Helmich LP, de Bastos DR, Sichero L, et al
Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma.
Mol Oncol. 2026;20:1643-1660.
PubMed
Abstract available

ABUDERMAN AA, Mohamed MA, Rasulov F, Abdukarimova RK, et al
Antiproliferative and Apoptotic Effects of Lavandula officinalis In Vitro by Inhibiting HeLa Cancer Cell Growth and Migration.
Biotechnol Appl Biochem. 2026;73:1295-1302.
PubMed
Abstract available

SCAIOLI G, Vari MG, Barbera G, Durbano A, et al
Invitation strategies for improving uptake in cervical, breast, and colorectal cancer screening: a systematic review.
Eur J Cancer Prev. 2026;35:330-342.
PubMed
Abstract available

WU Z, Lan D, He C, Li N, et al
IGFL2-AS1 is associated with poor prognosis in cervical cancer and promotes disease progression via the miR-126-5p/MACC1 axis.
Mol Biol Rep. 2026;53:970.
PubMed
Abstract available

OUCHI H, Chiyoda T, Sakai K, Shiraishi Y, et al
Para-Aortic Lymph Node Metastasis Detected by Sentinel Lymph Node Biopsy in Cervical Cancer Initially Presumed to be Stage IA2: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70377.
PubMed
Abstract available

SAJWANI N, Suchitha GP, Prasad TSK, Dagamajalu S, et al
Procaterol Enhances Cisplatin-Induced Cytotoxicity via Apoptosis, Oxidative Stress, and Cell Cycle Arrest in Breast and Cervical Cancer Cells.
OMICS. 2026 Jun 19:15578100261459475. doi: 10.1177/15578100261459475.
PubMed
Abstract available

VERMA N, Singh V
Blood-based Biomarkers in Cervical Cancer: The Emerging Role of Circulating Human Papillomavirus and Tumor Deoxyribonucleic Acid.
Ann Afr Med. 2026 Jun 19. doi: 10.4103.
PubMed
Abstract available

SHAKYA S, Paneru B, Uprety S, Acharya Y, et al
Acceptability of Self-sampling in Human Papillomavirus Deoxyribonucleic acid based Cervical Screening in Nepal: A Mixed-Methods Study.
Kathmandu Univ Med J (KUMJ). 2025;23:433-440.
PubMed
Abstract available

XU Z, Xu J, Gu Y, Ji Y, et al
Systematic review of self-management practices for vaginal irrigation among cervical cancer patients undergoing radiotherapy.
Front Oncol. 2026;16:1807898.
PubMed
Abstract available

ZHANG L, Fu H, Feng Y, Tian J, et al
Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes.
Front Oncol. 2026;16:1841456.
PubMed
Abstract available

BUNDUKI GK
Beyond H uman papillomavirus (HPV): why female genital schistosomiasis must be addressed in Africa's cervical cancer prevention agenda.
Acad Pathol. 2026;13:100274.
PubMed
Abstract available

WEI W, Ku D, Rutherford N
Prognostic Value of Combined FDG PET and MRI Analysis of Cervical Cancer: A Systematic Review and Meta-Analysis.
J Med Radiat Sci. 2026 Jun 18. doi: 10.1002/jmrs.70103.
PubMed
Abstract available

LIU F, Sun W, Ding B, Yu B, et al
Association between exposure to perfluoroalkyl ether sulfonate F-53B and cervical cancer risk and its mechanisms of cervical toxicity in Chinese women.
Ecotoxicol Environ Saf. 2026;320:120373.
PubMed
Abstract available

STALP JL, Schneider JA, Steinkasserer L, Hachenberg J, et al
Comparing clinical decision-making between colposcopists and large language models in cervical dysplasia management: a pilot prospective multicenter study.
Arch Gynecol Obstet. 2026;313:206.
PubMed
Abstract available

ZUBAIDAH T
A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer [Letter].
Int J Womens Health. 2026;18:628657.
PubMed

NOV P, Wang D, Tan M, Virak V, et al
Global, regional, and national burdens of human papillomavirus-associated cervical cancer attributable to sexually acquired human papillomavirus infections among individuals aged 10-54 years from 1990 to 2021: findings from the Global Burden of Diseas
Sex Med. 2026;14:qfag045.
PubMed
Abstract available

OLUBAYO GT, Bakare A, Salako J, Olufayo OE, et al
Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study.
Front Public Health. 2026;14:1834756.
PubMed
Abstract available

KAMEPALLI S, Chavana A, Ludwig M, Flanagan M, et al
Chemoradiation after chemotherapy for metastatic cervical cancer can provide chemo-free time.
Front Oncol. 2026;16:1826017.
PubMed
Abstract available

THOMSON M, Tessier KM, Jones C, Lim N, et al
Prevalence of Alcohol Use Disorder and Alcohol-related Liver Disease in Women Undergoing Cervical Cancer Screening: A Missed Opportunity to Screen?
J Addict Med. 2026 Jun 19. doi: 10.1097/ADM.0000000000001705.
PubMed
Abstract available

TAN S, Liu X, Li B, Bao T, et al
Node-RADS in cervical cancer: a multi-reader agreement and diagnostic performance study.
Cancer Imaging. 2026 Jun 17. doi: 10.1186/s40644-026-01072.
PubMed
Abstract available

AYENI OA, Mmereki D, Mistry H, Achilonu O, et al
Disease characteristics, treatment, and overall survival outcomes of patients with locally advanced cervical cancer referred for radiation therapy in Johannesburg, South Africa: a 2-year retrospective study.
BMC Womens Health. 2026 Jun 17. doi: 10.1186/s12905-026-04611.
PubMed
Abstract available

PORTNOY A, Burger EA
HPV vaccination and early declines in cervical cancer deaths.
Lancet. 2026 Jun 17:S0140-6736(26)01024-X. doi: 10.1016/S0140-6736(26)01024.
PubMed

SASIENI P, Falcaro M
Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data.
Lancet. 2026 Jun 17:S0140-6736(26)00918-9. doi: 10.1016/S0140-6736(26)00918.
PubMed
Abstract available

FEI Y, Mao Y, Cai W, Huang L, et al
Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential.
Int Immunopharmacol. 2026;185:117005.
PubMed
Abstract available

ZHANG MY, Abulajiang Y, Ji C, Yang SL, et al
Epidemiology and treatment options for cervical cancer patients aged <25?Years based on SEER database and real world research.
Surg Oncol. 2026;67:102480.
PubMed
Abstract available

SANGER G, Damongilala LJ, Lau V, Romano R, et al
Cytotoxic Activity of Halymenia durvillaei against Cervical Cancer Cells: In Vitro and Computational Evidence.
Cell Biochem Biophys. 2026 Jun 17. doi: 10.1007/s12013-026-02099.
PubMed
Abstract available

SAINI V, Guo Z, Yu J, Wu D, et al
Development of a novel, urine-based high-risk human papillomavirus polymerase chain reaction test to predict cervical intraepithelial neoplasia abnormalities associated with cervical cancer.
Microbiol Spectr. 2026 Jun 17:e0379625. doi: 10.1128/spectrum.03796.
PubMed
Abstract available

KONG Y, Zhu L, Xiao Y
Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case report.
Oncol Lett. 2026;32:327.
PubMed
Abstract available

OLWAL CO, Rathore U, Makanani SK, Kaushal P, et al
Paracrine signals from HIV-1-infected immune cells reprogram cervical cancer pathways.
iScience. 2026;29:116083.
PubMed
Abstract available

GUO L, Song L, Liu X, Zhang B, et al
Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.
Transl Cancer Res. 2026;15:393.
PubMed
Abstract available

HOU Y, Gao Y, Yan WM
A bibliometric analysis of global research in cervical cancer radiotherapy (2015-2024): trends, hotspots, and future directions.
Transl Cancer Res. 2026;15:389.
PubMed
Abstract available

BURANJIANG G, Xie L, Wang Y, Jin S, et al
WT1-AS acts as a tumor suppressor in cervical cancer via OSR2-mediated transcriptional activation.
Transl Cancer Res. 2026;15:386.
PubMed
Abstract available

WEN X, Zheng W, Zhai T, Wang Q, et al
Identifying and validating of prognostic genes associated with myeloid cell differentiation in cervical cancer: development of a risk model based on single-cell RNA sequencing combined with bulk RNA sequencing data.
Transl Cancer Res. 2026;15:390.
PubMed
Abstract available

LIU L, Zhang Q, Liu L, Wu Z, et al
Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
Cancer Manag Res. 2026;18:600310.
PubMed
Abstract available

RATHOD G, Swetha S, Nalini B
Cervical Cancer Screening in Elderly Women: Impact of Aging on Cytology and the Role of HPV Testing.
Curr Aging Sci. 2026 Jun 11. doi: 10.2174/0118746098435866260603051645.
PubMed
Abstract available

FUJITA T, Hyuga S, Adachi M, Onishi Y, et al
Maternal Hemodynamic Management Using the FloTrac Monitor During Ex Utero Intrapartum Treatment for a Giant Fetal Cervical Mass: A Case Report.
J Obstet Gynaecol Res. 2026;52:e70368.
PubMed
Abstract available

VEGA C, Medina N, Leon R, Fabelo H, et al
In-vivo detection of cervical cancer lesions using hyperspectral colposcopy.
Sci Rep. 2026 Jun 16. doi: 10.1038/s41598-026-58325.
PubMed
Abstract available

SASIENI P, Rix J
Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.
BMJ. 2026;393:e304038.
PubMed

ANDREE-EVARTS D, Carroll S, Osborne C, Clarke Z, et al
Case study: Innovative collaboration to connect Aboriginal women from rural New South Wales to world-class cancer treatment for cervical cancer.
J Med Imaging Radiat Sci. 2026;57:102449.
PubMed
Abstract available

LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
Economic incentives for cervical cancer screening: A qualitative study of healthcare professionals' perspectives.
Public Health. 2026;257:106385.
PubMed
Abstract available

XU M, Molina MA, Gomez-Martin C, Dekker MMHS, et al
Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing.
Transl Oncol. 2026;71:102857.
PubMed
Abstract available

OLUBODUN T, Luoga P, Adam J
Prevalence and determinants of cervical cancer screening among women aged 30-49 years in Nigeria: A population-based cross-sectional study.
PLOS Glob Public Health. 2026;6:e0006668.
PubMed
Abstract available

ZHOU J, Cai J, Zhang L, Zhu Y, et al
Effectiveness and cost-effectiveness of pembrolizumab in persistent, recurrent, or metastatic cervical cancer with PD-L1 CPS 1-10: secondary analysis of KEYNOTE-826 using innovative KMSubtraction.
Expert Rev Pharmacoecon Outcomes Res. 2026.
PubMed
Abstract available

TAN WM, Wang JQ, Li L, Liu XJ, et al
miR-133b induces antitumor immunity in cervical cancer through modulating CMTM6/PD-L1 axis.
Mol Genet Genomics. 2026;301:140.
PubMed
Abstract available

HALLIK R, Innos K, Janes J, Karro H, et al
Sociodemographic factors predicting preference for human papillomavirus self-sampling in cervical cancer screening: comparison of opt-out and opt-in strategies.
Eur J Cancer Prev. 2026 Jun 16. doi: 10.1097/CEJ.0000000000001028.
PubMed
Abstract available

YANG Y, He H, Lu R, Li Y, et al
Fluorescence-colorimetric dual-mode detection of cysteine in artificial urine with potential relevance to cervical cancer.
Anal Methods. 2026 Jun 10. doi: 10.1039/d6ay00473.
PubMed
Abstract available

FEREDE YA, Zeleke AM, Tassew WC, Abebe AD, et al
Cervical Cancer Screening Utilization and Its Associated Factors Among Women Living With HIV in Public Health Facilities of Gondar Town, Northwest Ethiopia.
J Int Assoc Provid AIDS Care. 2026;25:23259582261460521.
PubMed
Abstract available

CHALLGUA CH, Rodriguez DE, Goicolea I, Linander I, et al
Barriers and facilitators in access to cervical cancer secondary prevention in Cochabamba, Bolivia: a qualitative study of healthcare providers' perceptions.
BMC Prim Care. 2026;27:233.
PubMed
Abstract available

OMAR DI, Althobaiti S, Nabil N, Mohammed SG, et al
Human papillomavirus vaccination: knowledge, acceptance, and barriers among medical students. An Egyptian multicenter cross sectional study.
Sci Rep. 2026;16:18528.
PubMed
Abstract available

BIERRENBACH AL, Pungartnik PC, Goncalves Queijo R, Rego JG, et al
Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data.
Hum Vaccin Immunother. 2026;22:2684304.
PubMed
Abstract available

SHAN W, Shan Q, Xu X, Chen J, et al
A Machine Learning Framework for Predicting Nosocomial Escherichia coli Infections in Cervical Cancer.
Clin Lab. 2026;72.
PubMed
Abstract available

ZHANG T, Qian Q, Zhen Q, Zhang J, et al
Prevotella bivia promotes cervical cancer progression and modulates macrophage polarization, while Lactobacillus iners suppresses these processes: evidence from multiomics analysis.
mBio. 2026 Jun 15:e0037426. doi: 10.1128/mbio.00374.
PubMed
Abstract available

TAN H, Yang X
Effect of aesthetic nursing interventions on the health-related quality of life of cervical cancer patients after treatment.
Front Surg. 2026;13:1609977.
PubMed
Abstract available

SHINGHAL A, Sanyal S, Pradhan S, Kapoor AR, et al
Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy.
Adv Radiat Oncol. 2026;11:102044.
PubMed
Abstract available

HAO F, Cheng X, He J, Song S, et al
A bibliometric analysis and visualization of trends in cervical cancer screening technologies based on dual-database analysis.
Front Oncol. 2026;16:1829800.
PubMed
Abstract available

SOLEHATI T, Haroen H, Hazmi HB, Putri YHS, et al
Telehealth Pathways for Cervical Cancer Prevention: A Scoping Review of Strategies to Close the Screening Gap.
Int J Womens Health. 2026;18:590474.
PubMed
Abstract available

YAO H, Hao Z, Zhang X, Liu S, et al
Severe immune checkpoint inhibitor-induced 3M syndrome: a case report.
Front Immunol. 2026;17:1840526.
PubMed
Abstract available

LI Y, Zhang J, Wu S, Liu Z, et al
The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action.
Front Immunol. 2026;17:1826283.
PubMed
Abstract available

YAO S, Liu J, Dalisay F, Johnson BK, et al
Cervical Cancer Information Seeking in the Digital Communication Environment.
J Health Commun. 2026 Jun 15:1-11. doi: 10.1080/10810730.2026.2689090.
PubMed
Abstract available

FU H, Shakeel RS, Peng YB, Liu J, et al
Cinoplatin: An Efficient Platinum(IV) Prodrug Effective in Inhibiting the Growth of Cervical Cancer.
Chempluschem. 2026;91:e70191.
PubMed
Abstract available

BEVILACQUA F, Robba E, Berchialla P, Preti M, et al
Psychological distress and dyadic trust in Italian women awaiting colposcopy after positive cervical cancer screening: a cross-sectional study.
BMC Womens Health. 2026 Jun 15. doi: 10.1186/s12905-026-04500.
PubMed
Abstract available

SUN Y, Liu P, Ji M, Hao M, et al
The prognostic value of different HPV infection statuses in cervical cancer.
Sci Rep. 2026 Jun 14. doi: 10.1038/s41598-026-58010.
PubMed
Abstract available

LIU W, Wang XJ, Cui YM, Liu JC, et al
Clinicopathological and molecular characterization of HPV-associated cervical poorly cohesive carcinoma: a rare aggressive entity.
J Pathol Clin Res. 2026;12:e70100.
PubMed
Abstract available

POWELL J, Myers JB, Horns JJ, Woodle T, et al
Treatment-Related Risk of Urologic Adverse Events in Cervical Cancer Survivors.
Urology. 2026 Jun 14:S0090-4295(26)00370-5. doi: 10.1016/j.urology.2026.
PubMed
Abstract available

XIN R, Gong M, Guo J, Tian J, et al
Cervical cancer screening policy inequality worldwide: a systematic review of disparities in access and implementation.
J Transl Med. 2026 Jun 13. doi: 10.1186/s12967-026-08460.
PubMed
Abstract available

YACOUB N, Domizio ND, Ramanah R, Lepiller Q, et al
Prevalence and distribution of high-risk HPV in an organized hospital-based cervical cancer screening cohort.
J Gynecol Obstet Hum Reprod. 2026;55:103231.
PubMed
Abstract available

CI J, Wang C, Wang Y, Li D, et al
MICA/MICB-Mediated NKG2D Immune Escape in Cervical Cancer: Single-Cell Transcriptomic Mapping of Radionuclide Therapy Targets for Precision Radioimmunotherapy.
Cancer Biother Radiopharm. 2026 Jun 13:10849785261458459.
PubMed
Abstract available

SCHOLL S, Nery ED, Gestraud P, Halladjian M, et al
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.
Cancer Rep (Hoboken). 2026;9:e70599.
PubMed
Abstract available

YIN Y, Huang Y, Lin L, Cui M, et al
The role of miR-557 in modulating cervical cancer malignancy by targeting TAOK1.
Hereditas. 2026 Jun 12. doi: 10.1186/s41065-026-00695.
PubMed
Abstract available

HAMADA K, Umemiya M, Yamanoi K, Fukunishi T, et al
Nationwide trends in surgery selection and minimally invasive surgery for cervical cancer with preoperative T1B1/T1B2 disease in Japan.
Int J Clin Oncol. 2026 Jun 12. doi: 10.1007/s10147-026-03095.
PubMed
Abstract available

KANKARIA A, Shukla P, Vijayakumar M, Sachdeva A, et al
Enhancing screening, early diagnosis and treatment initiation of oral, breast and cervical cancer in selected districts of India: an implementation research protocol.
BMJ Open. 2026;16:e112428.
PubMed
Abstract available

MARTINEZ F, Durand C, Morel Z, Zanoune AD, et al
Organized cervical cancer screening in Brittany: follow-up at 1 year after a positive virological test with normal cytology.
J Gynecol Obstet Hum Reprod. 2026 Jun 12:103229.
PubMed
Abstract available

NICOLLS S, McClymont E, Lee M, Coutlee F, et al
Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.
J Acquir Immune Defic Syndr. 2026 Jun 5. doi: 10.1097/QAI.0000000000003902.
PubMed
Abstract available

FUSEGI A, Nishikawa K, Kon T, Kamata M, et al
Surgical de-escalation in early-stage cervical cancer: current evidence and future perspectives.
Jpn J Clin Oncol. 2026 Jun 12:hyag092. doi: 10.1093.
PubMed
Abstract available

PANG H, Zhu S, Lu Q, Zheng W, et al
LAT1 Promotes Immunosuppression in Cervical Cancer by Interacting With TRIM67 to Facilitate IRF3 Ubiquitination and Degradation.
FASEB J. 2026;40:e72041.
PubMed
Abstract available

SERTEL E
Diagnostic Accuracy Rate of Tertiary Center Colposcopy Unit.
Anal Cell Pathol (Amst). 2026;2026:e9307280.
PubMed
Abstract available

PASHA T, Radhakrishna N, Buchapudi RR, Pullan SS, et al
Impact of size of ovoids with Intra-cavitary Brachytherapy on dose to point A in patients with Cancer Cervix.
Gulf J Oncolog. 2025;1:28-34.
PubMed
Abstract available

LATSUZBAIA A, Keer SV, Broeck DV, Weyers S, et al
Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.
J Med Virol. 2026;98:e70982.
PubMed
Abstract available

GAO D, Wang X, Juan J, Bi H, et al
Prevalence and genotype distribution of cervical human papillomaviruses infection across cytology: A nationwide, cross-sectional study of over 1 million Chinese women from 2020 to 2024.
J Infect. 2026;93:106773.
PubMed
Abstract available

DERVEEUW S, Van Landschoot F, Willems S, Vanthomme K, et al
Navigating racialised healthcare: Intersectional experiences shaping cancer screening among Black women in Belgium.
Soc Sci Med. 2026;403:119449.
PubMed
Abstract available

BIZZARRI N, Schivardi G, Casarin J, Di Martino G, et al
The incidence of low volume metastases according to Silva pattern in cervical adenocarcinoma undergoing sentinel lymph node biopsy.
Eur J Surg Oncol. 2026;52:111875.
PubMed
Abstract available

REICH O, Regauer S
Two target cells for HPV infection at the cervix?
Virus Res. 2026;369:199754.
PubMed
Abstract available

GONZALEZ CANTO J, Burgos Teruel A, Burgos Isern MA
Prevalence and characteristics of HPV infection in the prevaccination and pre-screening era (2012-2022) in the Valencian Community.
Enferm Infecc Microbiol Clin (Engl Ed). 2026;44:503174.
PubMed
Abstract available

ZHENG S, Shao F, Shao L, Zhang L, et al
FHIT suppresses cervical squamous cell carcinoma progression by negatively regulating UBE2I-mediated SUMO modification of NOTCH1.
Cell Signal. 2026;145:112582.
PubMed
Abstract available

PSILOPATIS I, Vrettou K
Diagnostic Proficiency of Large Language Models in the Interpretation of Cervical Cytopathology.
Int J Gynecol Pathol. 2026;45:297-303.
PubMed
Abstract available

FAN L, Sowmya A, Meijering E, Yu Z, et al
Medical hierarchical image classification via dual-geometry image-text learning.
Med Image Anal. 2026;112:104120.
PubMed
Abstract available

LUO M, Wu J, Duan Z, Zhou D, et al
Analysis of factors affecting lesion or HPV clearance rate after photodynamic therapy of persistent cervical intraepithelial neoplasia grade 1.
Photodiagnosis Photodyn Ther. 2026;59:105491.
PubMed
Abstract available

QI W, Ma L, Cui S, Huang Z, et al
Evaluation of photodynamic therapy (PDT) of high-risk cervical low-grade squamous intraepithelial lesions (LSIL) - A single center experience.
Photodiagnosis Photodyn Ther. 2026;59:105490.
PubMed
Abstract available

HASEGAWA K, Kasuga Y, Ohnishi E, Nakabayashi K, et al
Vaginal microbiota composition in pregnant women following cervical conization and radical trachelectomy.
Sci Rep. 2026;16:18798.
PubMed
Abstract available

ZHANG G, Yang B
Progressive Activation of YAP1 in Human Papillomavirus-Associated Squamous Intraepithelial Lesions and Squamous Cell Carcinoma.
Lab Invest. 2026;106:106127.
PubMed
Abstract available

CHEN Y, Liu L, Chen Y, Wang Y, et al
Prognostic factors influencing the cure rate of 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) of High-grade squamous intraepithelial lesions (HSIL): A retrospective cohort study.
Photodiagnosis Photodyn Ther. 2026;59:105463.
PubMed
Abstract available

BAHMAD HF, Alloush F, Jaspe G, Abulaban A, et al
PRAME Immunohistochemical Expression as a Diagnostic Tool to Distinguish Between Endocervical and Endometrial Adenocarcinomas.
Int J Gynecol Pathol. 2026;45:274-284.
PubMed
Abstract available

CHEN M, Li H, Wang L, Li L, et al
Evaluation of the efficacy and safety of photodynamic therapy after laser pretreatment for treating cervical high-grade intraepithlial lesions in patients of childbearing age: a non-randomized controlled prospective study.
Photodiagnosis Photodyn Ther. 2026;59:105451.
PubMed
Abstract available

LEVIN G, Gilbert L, Pareja R, Fumagalli D, et al
Trachelectomy in decline: national trends, outcomes, and academic output across 3 major databases.
Am J Obstet Gynecol. 2026;235:123-131.
PubMed
Abstract available

EERO N, Aarno L, Qiang K, Veronika F, et al
Genotype and Age Shape the Risk of Persistent High-Risk HPV Infections.
Am J Obstet Gynecol. 2026 Feb 25:S0002-9378(26)00121.
PubMed
Abstract available

WANG Y, Shi Q, Zhou X, Qiu L, et al
A meta-analysis of photodynamic therapy in the treatment of cervical intraepithelial neoplasia: Based on randomized controlled trials.
Photodiagnosis Photodyn Ther. 2026;59:105408.
PubMed
Abstract available

MORICE M, Cedric MA, Mushendwa JA, Gulamhussein MA, et al
Human Papillomavirus Vaccine Uptake and its Determinants among Parents of Adolescent Girls in Tanga city, Tanzania.
J Community Health. 2026;51:378-385.
PubMed
Abstract available

GERYKOVA L, Laco J, Hornychova H, Kamaradova K, et al
Utility of HoxB13 in differential diagnosis of female genital tract lesions with putative prostatic differentiation.
Virchows Arch. 2026;488:1293-1302.
PubMed
Abstract available

AKINCI G, Aydin R
The Effect of Women's Perceptions of Their Nurses' Communication on Their Distress and Fear of Cancer During Colposcopy: A Multicenter Study.
Cancer Nurs. 2026;49:E352-E360.
PubMed
Abstract available

ZHANG B, Lin Y, Xie S, Zhu X, et al
Decoding the association between platinum resistance and HPV status in cervical cancer using organoid models.
BMC Biol. 2026 Jun 26. doi: 10.1186/s12915-026-02665.
PubMed
Abstract available

DONG H, Zhang J, Wu L, Zhang X, et al
Human papillomavirus 18 E6-specific Affibody inhibits cervical cancer cell proliferation and induces apoptosis.
Appl Microbiol Biotechnol. 2026 Jun 26. doi: 10.1007/s00253-026-13903.
PubMed
Abstract available

SOMPONGNAWAKIT K, Boonyapipat S, Saeaib N
Pretreatment systemic immune-inflammatory index (SII) for a prognostic impact in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Taiwan J Obstet Gynecol. 2026;65:774-781.
PubMed
Abstract available

SUH-BURGMANN EJ, Hung YY, Seo T, Carlson K, et al
Home Cervical Cancer Screening Uptake in a Large Community-Based General Screening Population.
JAMA Netw Open. 2026;9:e2620343.
PubMed

CHEN S, Zhang Y, Chen D, Dang J, et al
AI-assisted Radiomic Model for Cervical Cancer Recurrence Prediction: A Multicenter Retrospective Study with Experimental Validation.
Radiol Imaging Cancer. 2026;8:e250618.
PubMed
Abstract available

TALPE-NUNES V, Ribeiro AL, Nunes RA, Sobrinho JS, et al
GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis.
J Med Virol. 2026;98:e71034.
PubMed
Abstract available

SUI L, Yin R
Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990-2025): a multi-database bibliometric analysis.
Front Immunol. 2026;17:1835957.
PubMed
Abstract available

RAKHAT A, Aimagambetova G
Diagnostic Accuracy of Urine and Vaginal Self-Sampling for Detection of High-Risk Human Papillomavirus: A Systematic Review and Meta-Analysis.
Viruses. 2026;18:681.
PubMed
Abstract available

QIAO M, Wang X, Ren C, Li Q, et al
Polymer-Based Biomaterials for Local Therapy in Cervical Cancer: A Mini-Review.
Polymers (Basel). 2026;18:1460.
PubMed
Abstract available

RADU EA, Anton CI, Sima CS, Streinu-Cercel A, et al
Beyond HPV in Eastern Europe: Genotype Distribution, Molecular Biomarkers, Vaginal Microbiome, and Implications for Cervical Cancer Prevention.
Life (Basel). 2026;16:1039.
PubMed
Abstract available

TERRINONI M, Caputo V, Palisciano M, Mascellino G, et al
Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives.
Genes (Basel). 2026;17:714.
PubMed
Abstract available

MOUSTAKLI E, Makrydimas S, Oikonomou ED, Nakou A, et al
The Microbiome-Mitochondria-Extracellular Vesicle Axis in HPV Persistence and Cervical Carcinogenesis.
Genes (Basel). 2026;17:655.
PubMed
Abstract available

SUAREZ-RICO DO, Rizo de la Torre LDC, Zermeno-Ruiz M, Balleza-Alejandri LR, et al
Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression.
Int J Mol Sci. 2026;27:5616.
PubMed
Abstract available

GACUTA E, Zajkowska M, Lawicki M, Urban J, et al
Diagnostic Potential of Selected Matrilysins and Stromelysins in the Diagnosis of Gynecological Malignancies Based on ROC Curve Analysis.
Int J Mol Sci. 2026;27:5592.
PubMed
Abstract available

ZHANG L, Ouyang Z, Tan J, Li W, et al
Mechanistic Study of Matrix Stiffness Promoting Lymph Node Metastasis in Cervical Cancer by Regulating NETs Formation via Piezo1.
Int J Mol Sci. 2026;27:5431.
PubMed
Abstract available

JELSKI W, Okrasinska S, Mroczko J, Rutkowska W, et al
MicroRNAs as Biomarkers of Cervical Cancers.
Int J Mol Sci. 2026;27:5330.
PubMed
Abstract available

AYAG ME, Tuncer MC, Ozdemir I
Gallic Acid Enhances Carboplatin-Induced Antitumoral Responses in Cervical Cancer Cells Through Oxidative Stress-Associated Mitochondrial and Apoptotic Mechanisms.
Biomedicines. 2026;14:1399.
PubMed
Abstract available

JIAO B, Wang D, Wei J, Guan S, et al
Sevoflurane-Associated Plasma Extracellular Vesicles Promote Aggressive Phenotypes in Cervical Cancer Cells with Concurrent DG Remodeling and EGFR/PKCalpha/NF-kappaB Activation.
Biomedicines. 2026;14:1333.
PubMed
Abstract available

LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. Diagnostics 2026, 16, 1224.
Diagnostics (Basel). 2026;16:1764.
PubMed
Abstract available

ALYAMI AS
Advanced Diffusion MRI in Cervical Cancer: A Comprehensive Review.
Diagnostics (Basel). 2026;16:1870.
PubMed
Abstract available

SUN L, Tunishahan A, Li X
M2 macrophage-derived exosomes promote the malignant progression and glycolysis of cervical cancer via Msi1.
Hereditas. 2026 Jun 25. doi: 10.1186/s41065-026-00703.
PubMed
Abstract available

ZHAO Y, Liu R, Li M, Feng M, et al
Bovine lactoferrin induces apoptosis and modulates the transcriptomic landscape of HeLa cervical cancer cells.
Biol Direct. 2026 Jun 26. doi: 10.1186/s13062-026-00859.
PubMed
Abstract available

GAO F, Zeng Y, Jia L, He J, et al
Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression.
Cell Div. 2026 Jun 25. doi: 10.1186/s13008-026-00182.
PubMed
Abstract available

O'LEARY K
HPV vaccination linked to dramatic reduction in cervical cancer deaths.
Nat Med. 2026 Jun 25. doi: 10.1038/d41591-026-00033.
PubMed

YANG G, Wang W, Zhang C, Liu Y, et al
Dynamic multimodal radiomic model for survival prediction in cervical cancer: a multi-cohort study.
NPJ Precis Oncol. 2026 Jun 25. doi: 10.1038/s41698-026-01545.
PubMed
Abstract available

CHEN L, Li C, Xu C, Cai R, et al
Unravelling the Mechanism of Compound Kushen Injection in Treating Cervical Cancer Through Ferroptosis Regulation: An Integrated Network Pharmacology and Molecular Docking Study.
IET Syst Biol. 2026;20:e70075.
PubMed
Abstract available

YI H, Li S, Han Y, Li Q, et al
The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasis.
Transl Oncol. 2026;71:102884.
PubMed
Abstract available

MATSUNAGA R, Tamura J, Yamamoto K, Senuki K, et al
Evaluation of the Efficacy of Human Papillomavirus Screening Compared With Cytology Screening in Pregnant Women: Protocol for a Prospective Multicenter Trial.
JMIR Res Protoc. 2026;15:e86397.
PubMed
Abstract available

SAITO T, Sho K, Saida T, Sumiya T, et al
Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.
J Radiat Res. 2026 Jun 25:rrag043. doi: 10.1093.
PubMed
Abstract available

HEMPEL S, Gross S, Steinkasserer L, Theis L, et al
Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.
Arch Gynecol Obstet. 2026;313:210.
PubMed
Abstract available

THOMAS V, Devadasan JDC, John NO, Reddy JK, et al
Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence.
Cancer Causes Control. 2026;37:111.
PubMed
Abstract available

SORBYE SW, Antonsen M, Richardsen E
Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.
Pathogens. 2026;15:657.
PubMed
Abstract available

VILLAZANA-CALDERON B, Jimenez-Wences H, Garcia-Chavez JN, Martinez-Ramirez I, et al
HPV-16 E6 and E7 Oncoproteins Promote Cell Proliferation and Migration Through the miR-218-5p/PIK3C2A Axis.
Pathogens. 2026;15:648.
PubMed
Abstract available

SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
Genotype-Specific HPV mRNA Triage Improves Colposcopy Efficiency Compared with Cytology and ATHENA-Derived Triage: A Population-Based Study of HPV DNA-Positive Women.
Pathogens. 2026;15:584.
PubMed
Abstract available

LEE TS, Wang YC
Stage-Specific Healthcare Costs in Cervical Cancer and Cervical Intraepithelial Neoplasia: A Population-Based Analysis Informing Value-Based Oncology and Equitable Prevention.
Curr Oncol. 2026;33:329.
PubMed
Abstract available

ABRAHAM A, Mahajan S, Padda P, Kaur J, et al
Assessment of Total Delays and Their Associated Factors among Breast, Cervical, and Head and Neck Cancers in Northwestern India: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2026;27:2097-2105.
PubMed
Abstract available

BODHARE T, Bele S, Rajh B, Karthikeyan V, et al
Awareness of Cervical Cancer, Willingness, and Barriers to Cervical Cancer Screening among Women in Madurai: A Cross-Sectional Study in South India.
Asian Pac J Cancer Prev. 2026;27:2053-2060.
PubMed
Abstract available

TESHA NA, Jaiswal N, Ruhago G, Geue C, et al
Cost and cost-effectiveness of cervical cancer HPV DNA self-sampling: a systematic review.
BMJ Public Health. 2026;4:e004405.
PubMed
Abstract available

CENGIZ M, Zaim OC, Temiz BE, Grigore M, et al
Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.
Curr Opin Oncol. 2026 Jun 23. doi: 10.1097/CCO.0000000000001255.
PubMed
Abstract available

BELAYNEH Y, Abneh AA, Mengist A, Kassie TD, et al
Determinants of precancerous cervical lesions among women screened for cervical cancer at Debre Markos town public health facilities, Ethiopia.
Reprod Health. 2026 Jun 24. doi: 10.1186/s12978-026-02399.
PubMed
Abstract available

DANG S, Tang X, Li Q, Wu J, et al
Corrigendum to "Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration" [J Ethnopharmacol. (2026) 358 120966].
J Ethnopharmacol. 2026 Jun 24:122028. doi: 10.1016/j.jep.2026.122028.
PubMed

JIAN J, Xu L, Gong C, Huang Y, et al
Transformer-based magnetic resonance-to-computed tomography synthesis for radiotherapy for cervical cancer: model development and clinical evaluation.
Biomed Phys Eng Express. 2026 Jun 24. doi: 10.1088/2057-1976.
PubMed
Abstract available

KATARIA I, Jose S, Jebaraj P, Kumar R, et al
Living With Loss: The Caregiver Journey and Unmet Needs Across the Cervical Cancer Care Continuum in India.
JCO Glob Oncol. 2026;12:e2600031.
PubMed
Abstract available

OLADOYIN OO, Cuccaro P, Savas LS, Yu R, et al
Trust in Cancer Information Sources and Awareness of Human Papillomavirus as a Cause of Cervical Cancer Among US Adults.
JAMA Netw Open. 2026;9:e2620133.
PubMed
Abstract available

ZHENG B, Fan D, Zhou S
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.
Cancer Biol Med. 2026 Jun 22:j.issn.2095-3941.2026.0139.
PubMed

BADEMCI EG, Soysal D, Gunes M, Zengin A, et al
Early colposcopy in non-16/18 high-risk human papillomavirus positivity with normal cytology.
Rev Assoc Med Bras (1992). 2026;72:e20252178.
PubMed
Abstract available

DONG X, Zhang J, Liu W
A turn-on fluorescent biosensor based on CdTe quantum dots for sensitive and selective detection of APE1 activity in cervical cancer cell lysates.
Anal Methods. 2026 Jun 24. doi: 10.1039/d6ay00808.
PubMed
Abstract available

LI J, Huang X, Abulizi G, Hasim A, et al
Exosomal Oleic Acid Promotes Lymphangiogenesis and Nodal Metastasis in Cervical Cancer via the AKT/mTOR Pathway.
J Extracell Vesicles. 2026;15:e70328.
PubMed
Abstract available

SHEN J, Sun S, Xu Z, Wang X, et al
A rapid semi-automated trajectory planning method for non-coplanar interstitial brachytherapy in cervical cancer using a greedy algorithm.
Radiat Oncol. 2026 Jun 23. doi: 10.1186/s13014-026-02881.
PubMed
Abstract available

XIE Y, Yu C, Wang M, Lin Y, et al
HMGB1 promotes radiotherapy resistance in human cervical cancer HeLa cells through regulating the AMPK/mTOR signaling.
World J Surg Oncol. 2026 Jun 23. doi: 10.1186/s12957-026-04461.
PubMed
Abstract available

FENG M, Yu Y, Du J, Wang H, et al
Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.
BMC Biotechnol. 2026 Jun 23. doi: 10.1186/s12896-026-01193.
PubMed
Abstract available

ZHANG H, Xie L, Liu Y, Yang H, et al
Integrated bioinformatics, machine learning, and experimental validation identify a four-gene diagnostic signature for cervical cancer associated with PI3K/AKT signaling.
Sci Rep. 2026;16:19576.
PubMed
Abstract available

COOPER S, Wiysonge CS, Jama NA, Leon N, et al
Understanding the roots of hesitancy to unlock the game-changing impact of HPV vaccination: Insights from a global qualitative evidence synthesis.
Hum Vaccin Immunother. 2026;22:2681769.
PubMed
Abstract available

BAI J, Cui XL, Bo SJ, Sun L, et al
Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer.
Hum Vaccin Immunother. 2026;22:2664301.
PubMed
Abstract available

YANG H, Zheng Q, Li X, Wang J, et al
Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells.
Onco Targets Ther. 2026;19:613657.
PubMed
Abstract available

ZHANG Y, Wu Y, Wang Y, Yang J, et al
Perioperative Symptom Trajectories and a Risk Prediction Model for Cervical Cancer: A Prospective Longitudinal Study.
Int J Womens Health. 2026;18:613006.
PubMed
Abstract available

BUZUROVIC IM, Cormack RA
A Novel Adjustable Tandem and Ring Applicator for Improved Dosimetry in Cervical Cancer HDR Brachytherapy.
Technol Cancer Res Treat. 2026;25:15330338261463597.
PubMed
Abstract available

GU L, Zhu B, Liu C, Wu X, et al
Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical Cancer.
Oncologist. 2026 Jun 22:oyag236. doi: 10.1093.
PubMed
Abstract available

ZHANG Y, Ye Y, Zhong Q, Yan Z, et al
Advances and prospects of MIL-based drug delivery systems in the diagnosis and treatment of cervical cancer.
Dalton Trans. 2026 Jun 22. doi: 10.1039/d6dt00965.
PubMed
Abstract available

LAMBA P
Comment on: "Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.".
Clin Transl Radiat Oncol. 2026;59:101166.
PubMed

SITTIWONG W, Dankulchai P, Wongsuwan P, Prasartseree T, et al
Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965].
Clin Transl Radiat Oncol. 2026;59:101128.
PubMed
Abstract available

GOMES M, Li Z, Olaitan A, Gentry-Maharaj A, et al
Predictive modeling for cervical cancer: existing AI approaches and the emerging role of vaginal microbiome.
Front Netw Physiol. 2026;6:1799486.
PubMed
Abstract available

WANG J, Wang X, Xu J, Xu Q, et al
Cost-effectiveness of single-dose versus two-dose HPV vaccination: a Markov cohort modelling analysis of a Kenya-India LMIC composite.
Front Public Health. 2026;14:1833764.
PubMed
Abstract available

CHEN Y, Wen T, Wen X, Lai Z, et al
Treatment of HER2-Positive Brain Metastasis from Cervical Cancer Using Multimodal Therapy Including Pyrotinib: A Case Report.
Int J Womens Health. 2026;18:607409.
PubMed
Abstract available

ENEH SC, Idemili-Aronu N, Jemisenia JO, Olakunde BO, et al
Participation and Refusal in an Implementation Trial: Insights from the Accelerating Cervical Cancer Elimination through the Integration of Screen-and-Treat Services (ACCESS) Study.
Res Sq [Preprint]. 2026 Jun 11:rs.3.rs-9798338. doi: 10.21203/rs.3.rs-9798338.
PubMed
Abstract available

RAKHMANKULOVA A, Sakko Y, Gaipov A, Atageldiyeva K, et al
Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study.
Front Oncol. 2026;16:1820759.
PubMed
Abstract available

BOU ANTOUN N, Grose RP, Walker AJ, Modjtahedi H, et al
FGFR inhibitor resistance in cervical cancer: a role for integrin alpha2 and mTOR signalling.
Front Cell Dev Biol. 2026;14:1863679.
PubMed
Abstract available

BAI Y, Liang Y
Comparison of ThinPrep cytology and high-risk human papillomavirus testing with different triage protocols for cervical cancer screening.
Am J Transl Res. 2026;18:4314-4325.
PubMed
Abstract available

JERIP AR, Noni V, Senian AA, Bong ACS, et al
Mismatch Between Vaccine Targets and Endemic HPV Genotypes in Sarawak, East Malaysia: Implications for Cervical Cancer Prevention.
J Med Virol. 2026;98:e71010.
PubMed
Abstract available

SAKRAN W, Abdel-Hakim M, Abdel-Rashid RS
Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells).
Sci Rep. 2026;16:19198.
PubMed
Abstract available

ZHANG T, Yan Y, Yuan S, Yang T, et al
A novel HPV E6/E7-regulated long noncoding RNA CRL suppresses cervical intraepithelial neoplasia progression by attenuating ferroptosis.
Hum Cell. 2026;39:90.
PubMed
Abstract available

V P, K H, Karthikeyan S, Murugadoss H, et al
Health-related quality of life in patients with cervical cancer: a systematic review and meta-analysis of EQ?5D utility scores.
Sci Rep. 2026 Jun 20. doi: 10.1038/s41598-026-58466.
PubMed
Abstract available

PERKINS RB, Fontenot HB, Manassaram-Baptiste D, Scott AM, et al
The Prevention Gap: Cervical Cancer in Older Women.
Womens Health Issues. 2026 Jun 20:S1049-3867(26)00074.
PubMed

OUEDRAOGO TC, Bazie BVEJT, Simpore A, Ouattara AK, et al
Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.
Cell Mol Biol (Noisy-le-grand). 2026;72:30-43.
PubMed
Abstract available

KULKARNI A, Wiener HW, Boitano TKL, Szychowski JM, et al
Charleson and Elixhauser Comorbidity Indices in Predicting Mortality Among Young and Old Cervical Cancer Patients.
Cancer Med. 2026;15:e71973.
PubMed
Abstract available

MANYANGA P, Vasavada A, Murwira S, Gondongwe L, et al
Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.
Infect Agent Cancer. 2026 Jun 19. doi: 10.1186/s13027-026-00773.
PubMed
Abstract available

LEMOUPA MAKAJIO SH, Murtas M, Kenfack B, Vassilakos P, et al
Interventions involving community health workers and their effect on cervical cancer screening uptake in sub-Saharan Africa: a systematic review.
BMC Public Health. 2026 Jun 19. doi: 10.1186/s12889-026-28109.
PubMed
Abstract available

MAHASE E
HPV jab: cervical cancer deaths fall to zero in vaccinated young women, research shows.
BMJ. 2026;393:e100047.
PubMed

PENG L, Zhang Q, Zhang L, Dai Q, et al
Intra-nanocomposite resonance energy transfer-based electrochemiluminescence biosensor for cervical cancer microRNA assay.
Biosens Bioelectron. 2026;311:118937.
PubMed
Abstract available

GOSECKA M, Gosecki M, Urbaniak M, Wielgus E, et al
Unimolecular micelles as an effective carrier of poorly water-soluble nifuratel for selective in vivo anticervical cancer therapy via mucoadhesive dynamic hydrogels.
J Mater Chem B. 2026;14:7543-7557.
PubMed
Abstract available

CORDOVIL DC, da Silva Reis LD, Ferreira LSS, Sequeira CG, et al
High-risk oncogenic HPV genotypes in vulnerable women from the Amazon: a cross-sectional retrospective study.
Virol J. 2026;23:164.
PubMed
Abstract available

POULAIN F, Malassigne V, Roncarati P, Puech J, et al
Clonal origin and early lineage divergence in adenosquamous carcinoma.
Cell Rep. 2026;45:117470.
PubMed
Abstract available

CYRIAC J, Theel ES, Long ME, Maxson JA, et al
Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
J Low Genit Tract Dis. 2026;30:161-168.
PubMed
Abstract available

ONG P, Jainar CJ, Chua VH, Cabrera SM, et al
Integrating ultrasound into cervical brachytherapy planning: A technical note with an illustrative case.
Brachytherapy. 2026;25:640-647.
PubMed
Abstract available

NANYONJO G, De Paepe E, Wambuzi M, Kasule S, et al
Perceived barriers and facilitators to conventional cervical screening: a qualitative study among women, primary health workers and community representatives in Uganda.
BMC Health Serv Res. 2026;26:867.
PubMed
Abstract available

MURDOCH S, Donaghy B, Grant A, Sheen K, et al
Exploring Autistic People's Experiences of and Attitudes Towards Cervical Screening: A Mixed-Methods Study.
Autism. 2026;30:1738-1748.
PubMed
Abstract available

OZDEMIR BG, Agakishiyeva L, Bilgi A, Celik C, et al
Evaluation of Clitoral Artery Doppler Parameters After Brachytherapy and Its Effects On Sexual Functions.
J Low Genit Tract Dis. 2026;30:280-284.
PubMed
Abstract available

OWENS H, Griner SB, Beckstead J, Kim E, et al
Predictors of Intention to Use At-Home HPV Testing: Health Belief Factors and Potential Moderation by Decision-Making Style.
Womens Health Issues. 2026;36:286-293.
PubMed
Abstract available

DE SEIXAS CARVALHO B, Jordao PM, de Andrade CV, da Costa ACC, et al
Swede Score can predict high-grade cervical intraepithelial neoplasia without previous cytology in colposcopies with transformation zone types 1 or 2.
BMC Womens Health. 2026;26:158.
PubMed
Abstract available

TYAGI P, Rivera A, Chakraborty S, Bhattacharyya T, et al
Patterns of anesthesia(AS) and analgesia(AG) practice in gynecological brachytherapy in India.
Brachytherapy. 2026;25:632-639.
PubMed
Abstract available

REGO RM, Vale DB, Campos CS, Vasconcelos L, et al
Age distribution of high-risk HPV infection and cervical lesions in an unvaccinated adult Brazilian population within an organized screening program.
Sci Rep. 2026;16:4453.
PubMed
Abstract available

RICKFORD R, Rogers M, Gunn R, Wearmouth L, et al
Facilitating engagement: Individual meaning-making and relationship-based trust in women's experiences of cervical screening.
J Health Psychol. 2026;31:3196-3209.
PubMed
Abstract available

SLATER T, Stevenson K, Adcock A, Clueard MA, et al
Opportunities to flip the narrative from burden to action for young women joining the National Cervical Screening Programme in Aotearoa New Zealand: a Kaupapa Maori qualitative exploration of experiences and knowledge of cervical screening for 18-30 y
J Prim Health Care. 2026;18:141-148.
PubMed
Abstract available

OLTIEVA MP, Alieva DA, Kizi Abdusattorova SB, Sharipova IP, et al
Epidemiology of high-risk HPV in Uzbekistan among 44,000 women - genotypes, risk profiles and screening needs in Uzbekistan.
BMC Infect Dis. 2025;25:1721.
PubMed
Abstract available

CHEN M, Zhang W, Wu X, Wang H, et al
Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.
J Transl Med. 2025;24:38.
PubMed
Abstract available

XIE K, Hua Q, Gao L, Sun J, et al
SegMambaDP: a long-range sequential modeling mamba network for 3D dose prediction in radiotherapy.
BMC Med Imaging. 2025;25:527.
PubMed
Abstract available

ADDIS NA, Yigzaw KT, Ahmed OA, Yemru GM, et al
Cervical schistosomiasis masquerading as invasive carcinoma: a case report.
BMC Infect Dis. 2025;25:1654.
PubMed
Abstract available

SAD SA, Iftikhar L, Chamout M
Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.
Int J Equity Health. 2025;24:308.
PubMed
Abstract available

LI X, Sun B, Huang X
Trends and projections of global gynaecological cancer burden: age-period-cohort insights from Global Burden of Disease 2021.
BMC Womens Health. 2025;25:502.
PubMed
Abstract available

CHEN M, Wang Y, Dong B, Zhang Y, et al
Epidemiological analysis of human papillomavirus infection in senior women: a hospital-based retrospective study.
BMC Infect Dis. 2025;25:1378.
PubMed
Abstract available

XIAONAN L, MeiHan C, Dan H
Vaginal Microenvironment-Driven neural network model for predicting multiple HPV co-infections: a machine learning clinical decision framework.
BMC Womens Health. 2025;25:489.
PubMed
Abstract available

SIGVARDSSON D, MacLean A, Hoonk A, Ali T, et al
Barriers and implementation strategies for physical activity on prescription (PAP): healthcare personnel and management perspectives in Sweden-An explanatory sequential study design.
BMC Prim Care. 2025;26:302.
PubMed
Abstract available

JUAREZ-LEON V, Calderon-Solano D, Poterico JA, Ybaseta-Medina J, et al
Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru.
BMC Public Health. 2025;25:2334.
PubMed
Abstract available

MIYAMURA T, Mori S, Onuki M, Sekizawa A, et al
Nuclear keratin 6A upregulates human papillomavirus oncogene expression through TEAD1 interaction.
Virol J. 2025;22:202.
PubMed
Abstract available

KYLLONEN S, Saloranta S, Kares S, Mustila A, et al
Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.
Acta Obstet Gynecol Scand. 2026 Jun 4. doi: 10.1111/aogs.70273.
PubMed
Abstract available

ELLIS LB, Bowden SJ, Paraskevaidi M, Lyons D, et al
Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study.
Br J Cancer. 2026;135:118-126.
PubMed
Abstract available

ELLIS LB, Tighe J, Bowden SJ, Kechagias KS, et al
Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
Eur J Cancer. 2026;243:116823.
PubMed
Abstract available

FLANNELLY G, Leeson S, Jariene K, Kesic V, et al
The importance of quality assurance in colposcopy in the elimination of cervical cancer: A position paper by the European Federation for Colposcopy.
Eur J Obstet Gynecol Reprod Biol. 2026;324:115238.
PubMed
Abstract available

LIU F, Wang L, Sun Q, Jing S, et al
Adverse events associated with immune checkpoint inhibitors in cervical cancer: A systematic review and meta-analysis of randomized controlled trials.
Eur J Obstet Gynecol Reprod Biol. 2026;324:115263.
PubMed
Abstract available

WOLSWINKEL JT, Bekkers AHPA, Maurits JSF, Bekkers RLM, et al
Preoperative LVSI assessment in early-stage cervical cancer: Can it reliably guide lymph node management?
Gynecol Oncol. 2026;210:106-112.
PubMed
Abstract available

VALSTAD H, Fauske L, Wang YY, Eyjolfsdottir B, et al
Pelvic exenteration for cervical cancer - Oncologic outcome and long-term health-related quality of life, a mixed methods study.
Gynecol Oncol. 2026;210:183-192.
PubMed
Abstract available

ZHONG X, Jin X, Cheng Y, Chao X, et al
Clinical Utility of Cytological Methylation Assay in Cervical Cancer Screening Across Various Cervical Transformation Zones.
Int J Cancer. 2026 Jun 11. doi: 10.1002/ijc.70591.
PubMed
Abstract available

BHATLA N, Rol M, Singhal S, Hussain S, et al
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource Settings.
Int J Cancer. 2026 Jun 7. doi: 10.1002/ijc.70534.
PubMed
Abstract available

MENESES-LEON J, Rivera-Paredez B, Hernandez-Salazar S, Torres-Ibarra L, et al
Extended HPV typing as an efficient alternative within HPV-based screening programs.
Int J Cancer. 2026 Mar 28. doi: 10.1002/ijc.70428.
PubMed
Abstract available

CHOKUNONGA E, Chirenje ZM, Borok M, Makunike-Mutasa R, et al
Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990-2019.
Int J Cancer. 2026;159:844-852.
PubMed
Abstract available

RUSSELL JC, Amin S, Kohler RE, Kelly H, et al
Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
Int J Gynaecol Obstet. 2026 May 26. doi: 10.1002/ijgo.71089.
PubMed
Abstract available

DORJI N, Dorjey Y, Tshering S, Bhujel D, et al
Status of human papillomavirus infection after loop electrosurgical excision procedure at the National Referral Hospital, Bhutan, 2022-2023: A retrospective study.
Int J Gynaecol Obstet. 2026;174:145-151.
PubMed
Abstract available

TJOKROPRAWIRO BA
TeleDoIVA: expanding cervical cancer screening across Indonesia's Archipelago through smartphone-based teleconsultation.
Int J Gynecol Cancer. 2026 Apr 25:104723. doi: 10.1016/j.ijgc.2026.104723.
PubMed

TEODORICO E, Moro F, Criscione M, Culcasi C, et al
Ultrasound detection of residual cervical cancer after conization, in a retrospective monocentric analysis: the URECA study.
Int J Gynecol Cancer. 2026;36:104755.
PubMed
Abstract available

LEVIN G, Gilbert L, Pareja R, Leung SOA, et al
Impact of bilateral oophorectomy on survival among patients undergoing radical hysterectomy for cervical adenocarcinoma: a National Cancer Database analysis.
Int J Gynecol Cancer. 2026;36:104469.
PubMed
Abstract available

VERIT FF
From biological plausibility to clinical uncertainty: poly(adenosine diphosphate-ribose) polymerase-based strategies in recurrent cervical cancer.
Int J Gynecol Cancer. 2026;36:104771.
PubMed

RUBAGUMYA F, Shankar V, Kwizera V, Ndoli DA, et al
Survival outcomes of cervical cancer patients treated with external beam radiotherapy boost in Rwanda.
Int J Gynecol Cancer. 2026;36:104754.
PubMed
Abstract available

JOURA E, Chatzistamatiou K, Gultekin M, Sehouli J, et al
European Society of Gynaecological Oncology/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening.
Int J Gynecol Cancer. 2026;36:104794.
PubMed
Abstract available

CARUSO G, Colombo N
ADC-opoly in endometrial and cervical cancer: expanding the board.
Int J Gynecol Cancer. 2026;36:104786.
PubMed

MAYADEV J, Deng W, Kim H, Xiao Y, et al
Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
Int J Radiat Oncol Biol Phys. 2026 May 24:S0360-3016(26)00706.
PubMed
Abstract available

CHARNALIA M, Ranjan N, Spampinato S, Nout R, et al
Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life.
Radiother Oncol. 2026;219:111489.
PubMed
Abstract available

YANG XL, Li XM, Shi YG, Wei LC, et al
Induction chemotherapy prior to definitive chemoradiotherapy in locally advanced cervical cancer patients: A multi-center cohort study.
Radiother Oncol. 2026 Jun 26:111675. doi: 10.1016/j.radonc.2026.111675.
PubMed
Abstract available

DUDUYEMI BM, Mensah BNO, Addae EK, Sallah L, et al
Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study.
BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16266.
PubMed
Abstract available

HE Y, Yang H, Zhang C, Jiang R, et al
Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women.
BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16208.
PubMed
Abstract available

ADEGBOYEGA B, Balogun O, Ogunmuyiwa J, Habeebu M, et al
Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centre.
BMC Cancer. 2026 Jun 9. doi: 10.1186/s12885-026-16311.
PubMed
Abstract available

WU J, He W, Zhang W, Ye D, et al
EVX2 methylation assay enables risk assessment of cervical cancer in high-risk HPV-infected individuals.
BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16256.
PubMed
Abstract available

ADEBISI TM, Oluwasola TAO, Ndikom CM, Salako BL, et al
Feasibility of the effectiveness of a psychoeducational intervention on the physical and psychosexual functioning of women being treated for cervical cancer in a tertiary hospital in Southwest, Nigeria: a quasi-experimental study.
BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16288.
PubMed
Abstract available

CHEN Y, Li S, Huang J, Huang X, et al
Cervical pathology outcomes in the setting of completely normal colposcopic impressions.
BMC Cancer. 2025;25:1691.
PubMed
Abstract available

FARZANEH F, Soltani A, Dastyar F, Mohammadi M, et al
AI-Driven predictive modeling of cervical intraepithelial neoplasia severity: a comprehensive analysis with clinical adoption frameworks.
BMC Cancer. 2025;25:1521.
PubMed
Abstract available

WANG XC, Xu XL, Wang SY, Cheng H, et al
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy.
BMC Cancer. 2025;25:1043.
PubMed
Abstract available

BUTTA J, Thonghoi P, Kesakul T, Thoopthong A, et al
Incremental impact of community-delivered HPV self-sampling on screening uptake within an active outreach system: A quasi-experimental implementation study in rural Thailand.
PLoS One. 2026;21:e0349531.
PubMed
Abstract available

YANG S, Hou Y, Wang X, Kang S, et al
Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
PLoS One. 2026;21:e0351029.
PubMed
Abstract available

CHEN S, Yang X, Jiang S, Lin Y, et al
Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
PLoS One. 2026;21:e0351539.
PubMed
Abstract available

EZECHUKWU C, Ayandipo EO, Osoteku D, Ibrahim R, et al
Gaps and barriers preventing sustained delivery of HPV vaccination in Kano, Kaduna, and Lagos states: An exploratory qualitative study.
PLoS One. 2026;21:e0350510.
PubMed
Abstract available

MUHAMMAD-OLODO AO, Asher L
Understanding factors influencing HPV vaccine uptake among caregivers in Kwara State, Nigeria: A qualitative study.
PLoS One. 2026;21:e0351659.
PubMed
Abstract available

NOREEN K, Noor M, Maryam S, Baig M, et al
From global to local: Developing a context-specific BeSD-HPV tool through cultural and linguistic adaptation in Pakistan.
PLoS One. 2026;21:e0350162.
PubMed
Abstract available

ILGAZI KILIC E, Kilic S
Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.
PLoS One. 2026;21:e0351063.
PubMed
Abstract available

NEEMA UFOY MUNGU Y, Desreux J, Bianchi E, Junior BL, et al
Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo.
PLoS One. 2026;21:e0350982.
PubMed
Abstract available

EFFAH K, Ametefe DL, Amuah JE, Essel NOM, et al
A collaborative cervical precancer screening strategy with concurrent HPV genotyping and visual inspection using alumni of a training centre across Ghana: The Rotary 'Protect Your Pearl' initiative.
PLoS One. 2026;21:e0350573.
PubMed
Abstract available

SEDAGHAT SHAYEGAN G, Salehipour P, Najafi A, Modarressi MH, et al
Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach.
PLoS One. 2026;21:e0349088.
PubMed
Abstract available

RIETZ A, Kumari L, Koirala A, Pelletier S, et al
Covalent inhibitors of human papillomavirus type 16 E6 protein restore p53 function and suppress growth of HPV-driven tumors in vivo.
Proc Natl Acad Sci U S A. 2026;123:e2606213123.
PubMed
Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum

;